Composants du site
@ Possibilité de renseigner un crédit photo
- EN
- FR
- EN
- FR
Panorama des widgets dans un WYSIWYG
Texte explicatif
Lorem ipsum
Lorem ipsum
Lorem ipsum
Nom de l'auteur de la citation
Texte de la citation
Citation ou texte mis en avant
Auteur de la citationPoste
Lorem ipsum dolor
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Maxime, expedita.
Lorem ipsum dolor
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Maxime, expedita.
Titre
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris.
Question ?
Réponse
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
TITRE
CONTENU
LIENS
Contenu > Ajouter un bloc
Faites un don pour la recherche
Help the research
Donate !Soutenir le centre d'enseignement
Soutenir le centre d'enseignement
Former les meilleurs chercheurs pour vaincre les maladies
Nos recherches Sars-Cov-2
Découvrez notre mobilisation et l'impact de nos recherches dans la réponse à la crise Covid-19.
Accédez également à l'ensemble de nos publications scientifiques ainsi qu'aux modélisations mathématiques sur la dynamique de l’épidémie et l'impact des mesures de contrôle.
Ressources pour la presse
Ressources pour la presse
Retrouvez les ressources et documents présentant l'Institut Pasteur et ses activités : le rapport annuel, l’accès à la photothèque…
Assu 2000
Depuis maintenant plus de 10 ans, ASSU 2000 est partenaire du Pasteurdon et soutient les recherches sur le microbiote intestinal. À nouveau cette année, le courtier en assurance versera 2 euros à l’Institut Pasteur pour toute souscription de contrats d’assurance (automobile, 2 roues, santé et prévoyance).
Portraits des doctorants - Cérémonie 2020
Cérémonie doctorants 2020
Photo de groupe
Cérémonie doctorants 2020
Emilie Bierque
Cérémonie doctorants 2020
Zhenghui Huang
Cérémonie doctorants 2020
Laetitia Lesire
Cérémonie doctorants 2020
Mélissa Mairet-Khedim
Cérémonie doctorants 2020
Sitraka Rakotosamimanana
Cérémonie doctorants 2020
Rila Ratovoson
Cérémonie doctorants 2020
Camille Roesch
Cérémonie doctorants 2020
Serges Tchatchouang
Cérémonie doctorants 2020
Marilena Tsala
Cérémonie doctorants 2020
Florian Bakoa
Cérémonie doctorants 2020
Nathalie Bechon
Cérémonie doctorants 2020
Adam Benabid
Cérémonie doctorants 2020
Maria Benavente Diaz
Cérémonie doctorants 2020
Pablo Canales Herrerias
Cérémonie doctorants 2020
Eva Conde Garcia
Cérémonie doctorants 2020
Iryna Denega
Cérémonie doctorants 2020
Morgane Grand
Cérémonie doctorants 2020
Alexandre Grimaldi
Cérémonie doctorants 2020
Surya Koturan
Cérémonie doctorants 2020
Livia Lacerda Mariano
Cérémonie doctorants 2020
Valérie Lorin
Cérémonie doctorants 2020
Chak Hon Luk
Cérémonie doctorants 2020
Nicolas Malausse
Cérémonie doctorants 2020
Adeline Mallet
Cérémonie doctorants 2020
Laure Mancini
Cérémonie doctorants 2020
Timéa Marton
Cérémonie doctorants 2020
Maria Vittoria Mazzuoli
Cérémonie doctorants 2020
José Americo Nabuco
Cérémonie doctorants 2020
Gizem Ozbaykal
Cérémonie doctorants 2020
Giulia Pinto
Cérémonie doctorants 2020
Irène Pitard
Cérémonie doctorants 2020
Lucie Poggi
Cérémonie doctorants 2020
Céline Posseme
Cérémonie doctorants 2020
Piergiuseppe Quarato
Cérémonie doctorants 2020
Philippe Rascle
Cérémonie doctorants 2020
Yamini Ravichandran
Cérémonie doctorants 2020
Laura Salavessa
Cérémonie doctorants 2020
Shailaja Seetharaman
Cérémonie doctorants 2020
Adria Sogues Castrejon
Cérémonie doctorants 2020
Diana Baquero
Cérémonie doctorants 2020
Coralie Cazin
Cérémonie doctorants 2020
Paulo André Dias Bastos
Cérémonie doctorants 2020
Magali Dupont
Cérémonie doctorants 2020
Marion Opatowski
Cérémonie doctorants 2020
Alexis Proutière
Cérémonie doctorants 2020
Marc Ravatin
Cérémonie doctorants 2020
François Rousset
Responsive
| Titre | Auteur | Date | Source | Publication |
|---|---|---|---|---|
| MSclassifR: An R package for supervised classification of mass spectra with machine learning methods | Godmer A. et al. | 2025 | Expert Systems with Applications 294, 128796 | 10.1016/j.eswa.2025.128796 |
| The SARS-CoV-2 envelope PDZ binding motif acts as a virulence factor disrupting host’s epithelial cell–cell junctions | Alvarez F. et al. | 2025 | Cellular and Molecular Biology Letters 30 (1), 80 | 10.1186/s11658-025-00758-y |
| Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization | Dugied G. et al. | 2025 | Communications Biology 8 (1), 501 | 10.1038/s42003-025-07933-z |
| Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem | Coleon A. et al. | 2025 | Nature Communications 16 (1), 6714 | 10.1038/s41467-025-62048-7 |
| Evolution of social contacts patterns in France over the SARS-CoV-2 pandemic: results from the SocialCov survey | Soussand F. et al. | 2025 | BMC Infectious Diseases 25 (1), 224 | 10.1186/s12879-025-10611-4 |
| Extracting circumstances of Covid-19 transmission from free text with large language models | Bizel-Bizellot G. et al. | 2025 | Nature Communications 16 (1), 5836 | 10.1038/s41467-025-60762-w |
| Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients | Scalzo P.L. et al. | 2025 | Journal of Translational Medicine 23 (1), 327 | 10.1186/s12967-025-06348-y |
| RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques | Letscher H. et al. | 2025 | Npj Vaccines 10 (1), 63 | 10.1038/s41541-025-01113-0 |
| Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics | Perochon T. et al. | 2025 | Nature Communications 16 (1), 1577 | 10.1038/s41467-025-56560-z |
| Impact of COVID-19 on urgent gastrointestinal surgery outcomes: increased mortality in 2020 | Gouel-Chéron A. ; Sallah K. ; Sawadogo S. ; Dupont A. ; Montravers P. | 2025 | World Journal of Emergency Surgery 20 (1), 23 | 10.1186/s13017-025-00589-4 |
| Are psychological attitudes towards vaccination an expression of personality? A cross-sectional study on COVID-19 vaccination in France | Lièvre G. et al. | 2025 | BMC Public Health 25 (1), 209 | 10.1186/s12889-025-21364-9 |
| Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study | Al Rahmoun M. ; Sabaté-Elabbadi A. ; Guillemot D. ; Brun-Buisson C. ; Watier L. | 2025 | BMC Infectious Diseases 25 (1), 627 | 10.1186/s12879-025-11000-7 |
| Motivation to continue and the value of care work among French Red Cross volunteers and workers during the COVID-19 pandemic: a mixed methods study | Heyerdahl L.W. ; Guillemot V. ; Lana B. ; Bizel-Bizellot G. ; Giles-Vernick T. | 2025 | BMC Public Health 25 (1), 1305 | 10.1186/s12889-025-22406-y |
| Understanding the interplay between epidemiological and social cognitve drivers of behaviour change during the Covid-19 pandemic | McColl K. et al. | 2025 | Scientific Reports 15 (1), 30556 | 10.1038/s41598-025-14644-2 |
| Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial | Renard Triché L. et al. | 2025 | Anaesthesia Critical Care and Pain Medicine 44 (5), 101559 | 10.1016/j.accpm.2025.101559 |
| Design, synthesis, biophysical and biological evaluation of original condensed pyrrolopyrimidine and pyrrolopyridine ligands as anti-SARS-CoV-2 agents targeting G4 | Guillon J. et al. | 2025 | European Journal of Medicinal Chemistry 292, 117655 | 10.1016/j.ejmech.2025.117655 |
| The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population | Lanièce Delaunay C. et al. | 2025 | International Journal of Epidemiology 54 (4), dyaf086 | 10.1093/ije/dyaf086 |
| Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells | Baid K. et al. | 2025 | Cell Reports 44 (7), 115929 | 10.1016/j.celrep.2025.115929 |
| Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains | Saidoune F. et al. | 2025 | Journal of Experimental Medicine 222 (7) | 10.1084/jem.20231467 |
| Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms | Beretta M. et al. | 2025 | Rmd Open 11 (3), e005673 | 10.1136/rmdopen-2025-005673 |
| Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selection | Saha P. et al. | 2025 | Nature Nanotechnology 20 (7), pp. 926-934 | 10.1038/s41565-025-01908-1 |
| Epistemic preparedness | Anderson W. et al. | 2025 | BMJ Global Health 10 (6), e018719 | 10.1136/bmjgh-2024-018719 |
| A MERS-CoV-like mink coronavirus uses ACE2 as an entry receptor | Wang N. et al. | 2025 | Nature 642 (8068), pp. 739-746 | 10.1038/s41586-025-09007-w |
| Multiplex ACE2-RBD binding inhibition assay: An integrated tool for assessing neutralizing antibodies to SARS-CoV-2 variants and protection against breakthrough infections | Bloch E. et al. | 2025 | Journal of Immunological Methods 541, 113886 | 10.1016/j.jim.2025.113886 |
| How COVID-19 affected academic publishing: a 3-year study of 17 million research papers | Whitaker M. et al. | 2025 | International Journal of Epidemiology 54 (3), dyaf058 | 10.1093/ije/dyaf058 |
| Troubled Times, Changing Tides: A Seroprevalence Study on Meningococcal Immunity in France Between 2016 and 2024 | Taha S. ; Terrade A. ; Doucoure O. ; Deghmane A.E. ; Taha M.K. | 2025 | Vaccines 13 (6), 647 | 10.3390/vaccines13060647 |
| Targeting the SARS-CoV-2 reservoir in long COVID | Proal A.D. et al. | 2025 | Lancet Infectious Diseases 25 (5), pp. e294-e306 | 10.1016/S1473-3099(24)00769-2 |
| COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024–January 2025, VEBIS Primary Care Network | Laniece Delaunay C. et al. | 2025 | Influenza and Other Respiratory Viruses 19 (5), e70120 | 10.1111/irv.70120 |
| Hospitalisations for physical abuse in infants and children less than 5 years, 2013–2021: a multinational cohort study using administrative data from five European countries | Quantin C. et al. | 2025 | Lancet Regional Health Europe 52, 101270 | 10.1016/j.lanepe.2025.101270 |
| Using the near real-time effective reproduction number Rt as an early-warning tool for seasonal bronchiolitis and influenza-like illness epidemics | Gallien Y. et al. | 2025 | American Journal of Epidemiology 194 (5), pp. 1332-1340 | 10.1093/aje/kwae195 |
| Seizures and Lung Lesions in a Solid Organ Transplant Recipient: Bringing Things Together | Roberts M.B. ; Coussement J. ; Lebeaux D. ; Coates P.T. ; Clemente W.T. | 2025 | Transplant Infectious Disease 27 (3), e14449 | 10.1111/tid.14449 |
| Prescription Trends of Medications Used to Treat Sleep Disturbances in School-Aged Children: An Interrupted Time-Series Analysis in France, 2016-2023 | Valtuille Z. et al. | 2025 | Journal of Pediatrics 280, 114502 | 10.1016/j.jpeds.2025.114502 |
| Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS) | Cortier T. et al. | 2025 | Journal of Infectious Diseases 231 (4), pp. e734-e742 | 10.1093/infdis/jiaf001 |
| Clinical characteristics of cases during the 2024 pertussis epidemic in France, January 2024 to December 2024 | Monchausse T. et al. | 2025 | Vaccine 51, 126862 | 10.1016/j.vaccine.2025.126862 |
| Association of TNFRSF13B Gene Polymorphisms With SARS-CoV-2 Infection, Severity, and Humoral Immune Response in a Moroccan Population | Laazaazia O. et al. | 2025 | International Journal of Immunogenetics 52 (2), pp. 75-87 | 10.1111/iji.12709 |
| The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance | Shaw D. et al. | 2025 | Lancet Digital Health 7 (4), pp. e275-e281 | 10.1016/S2589-7500(24)00241-3 |
| PLUMED Tutorials: A collaborative, community-driven learning ecosystem | Tribello G.A. et al. | 2025 | Journal of Chemical Physics 162 (9), 092501 | 10.1063/5.0251501 |
| Noncovalent Inhibitors of SARS-CoV-2 Main Protease: A Rescaffolding Attempt | Krischuns T. et al. | 2025 | Synthesis Germany 57 (9), pp. 1627-1634 | 10.1055/a-2519-9876 |
| Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database | Boulefaa D. et al. | 2025 | Drug Safety 48 (3), pp. 251-263 | 10.1007/s40264-024-01495-5 |
| Obituary Tomasz Skirecki (May 22nd, 1987–January 21st, 2025) | Osuchowski M. ; Cavaillon J.M. | 2025 | Microbes and Infection 27 (3), 105482 | 10.1016/j.micinf.2025.105482 |
| The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis | Brown L. et al. | 2025 | Eclinicalmedicine 81, 103115 | 10.1016/j.eclinm.2025.103115 |
| Artificial intelligence for modelling infectious disease epidemics | Kraemer M.U.G. et al. | 2025 | Nature 638 (8051), pp. 623-635 | 10.1038/s41586-024-08564-w |
| A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity | Al Qureshah F. et al. | 2025 | Journal of Experimental Medicine 222 (2), e20241413 | 10.1084/jem.20241413 |
| Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA-COVID-19 vaccine compared with unexposed infants: a COVI-PREG prospective cohort study | Favre G. et al. | 2025 | Clinical Microbiology and Infection 31 (2), pp. 266-273 | 10.1016/j.cmi.2024.10.019 |
| High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination | Rubio R. et al. | 2025 | Microbes and Infection 27 (2), 105423 | 10.1016/j.micinf.2024.105423 |
| Pneumonia and pregnancy | Shalaby A. ; Lachâtre M. ; Charlier C. | 2025 | Revue Des Maladies Respiratoires 42 (2), pp. 104-116 | 10.1016/j.rmr.2025.01.002 |
| Interferon γ and persistence of SARS-CoV-2 virus: Between viral replication control and immune evasion | Müller-Trutwin M. ; Huot N. | 2025 | Medecine Sciences M S 41 (2), pp. 118-120 | 10.1051/medsci/2025003 |
| From the 100 Day Mission to 100 lines of software development: how to improve early outbreak analytics | Tamayo Cuartero C. et al. | 2025 | Lancet Digital Health 7 (2), pp. e161-e166 | 10.1016/S2589-7500(24)00218-8 |
| Trends in Healthcare-Acquired Infections Due to Multidrug-Resistant Organisms at a German University Medical Center Before and During the COVID-19 Pandemic | Kolbe-Busch S. ; Djouela Djoulako P.D. ; Stingu C.S. | 2025 | Microorganisms 13 (2), 274 | 10.3390/microorganisms13020274 |
| Learning the fitness dynamics of pathogens from phylogenies | Lefrancq N. et al. | 2025 | Nature 637 (8046), pp. 683-690 | 10.1038/s41586-024-08309-9 |
| Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024 | Traore A. et al. | 2025 | Eurosurveillance 30 (1), 2400293 | 10.2807/1560-7917.ES.2025.30.1.2400293 |
| Correlates of Protection Against Symptomatic COVID-19: The CORSER 5 Case-Control Study | Beeker L. et al. | 2025 | Open Forum Infectious Diseases 12 (1), ofaf006 | 10.1093/ofid/ofaf006 |
| SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts | Bolland W. et al. | 2025 | Journal of Virology 99 (1) | 10.1128/jvi.01823-24 |
| Vaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023–2024 | Abou Chakra C.N. et al. | 2025 | Emerging Microbes and Infections 14 (1), 2466699 | 10.1080/22221751.2025.2466699 |
| SARS-CoV-2 IgG Seroprevalence in the Okinawa Main Island and Remote Islands in Okinawa, Japan, 2020–2021 | Takayama Y. et al. | 2025 | Japanese Journal of Infectious Diseases 78 (1), pp. 8-18 | 10.7883/yoken.JJID.2023.255 |
| Retaining African networks is urgent for global health | Bhiman J.N. et al. | 2025 | Trends in Microbiology | 10.1016/j.tim.2025.07.002 |
| Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic | Gendron N. et al. | 2025 | Research and Practice in Thrombosis and Haemostasis 9 (1), 102701 | 10.1016/j.rpth.2025.102701 |
| Invasive group A streptococcal infections: lessons learned from the 2022–23 upsurge | Flamant A. et al. | 2025 | Lancet Infectious Diseases | 10.1016/S1473-3099(25)00343-3 |
| Using Qualitative Research in Community Engagement to Capture and Mitigate Vulnerability Mechanisms in the Face of Infectious Diseases: Insights From a Research-Based Program in Five European Countries During the COVID-19 Pandemic | Geise M. et al. | 2025 | Qualitative Health Research , 10497323251346407 | 10.1177/10497323251346407 |
| A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification | Rosen L.E. et al. | 2024 | Cell 187 (25), pp. 7196-7213.e26 | 10.1016/j.cell.2024.09.026 |
| SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study | Mendiboure V. et al. | 2024 | BMC Public Health 24 (1) | 10.1186/s12889-024-17869-4 |
| SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave | Pouquet M. et al. | 2024 | Scientific Reports 14 (1), 5418 | 10.1038/s41598-024-55477-9 |
| Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling | Saunders N. et al. | 2024 | Nature Communications 15 (1), 4996 | 10.1038/s41467-024-49260-7 |
| Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022 | Galmiche S. et al. | 2024 | BMC Public Health 24 (1), 2411 | 10.1186/s12889-024-19651-y |
| Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature | Holtz A. et al. | 2024 | BMC Infectious Diseases 24 (1), 1139 | 10.1186/s12879-024-09967-w |
| Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion | Planas D. et al. | 2024 | Nature Communications 15 (1), 2254 | 10.1038/s41467-024-46490-7 |
| Addressing current limitations of household transmission studies by collecting contact data | Layan M. et al. | 2024 | American Journal of Epidemiology 193 (12), pp. 1832-1839 | 10.1093/aje/kwae106 |
| Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan | Takayama Y. et al. | 2024 | BMC Infectious Diseases 24 (1), 542 | 10.1186/s12879-024-09427-5 |
| The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies | Izadi A. et al. | 2024 | Nature Communications 15 (1), 3600 | 10.1038/s41467-024-47928-8 |
| Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths | Brault A. et al. | 2024 | BMC Infectious Diseases 24 (1), 467 | 10.1186/s12879-024-09304-1 |
| Correction to: Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan (BMC Infectious Diseases, (2024), 24, 1, (542), 10.1186/s12879-024-09427-5) | Takayama Y. et al. | 2024 | BMC Infectious Diseases 24 (1), 621 | 10.1186/s12879-024-09533-4 |
| Modelling the effectiveness of antiviral treatment strategies to prevent household transmission of acute respiratory viruses | Zaaraoui H. et al. | 2024 | Plos Computational Biology 20 (12), e1012573 | 10.1371/journal.pcbi.1012573 |
| Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia | Taouk M.L. et al. | 2024 | Nature Communications 15 (1), 8076 | 10.1038/s41467-024-52343-0 |
| Evolutionary origin and population diversity of a cryptic hybrid pathogen | Steenwyk J.L. et al. | 2024 | Nature Communications 15 (1), 8412 | 10.1038/s41467-024-52639-1 |
| Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April–June 2020) | Shirreff G. et al. | 2024 | Scientific Reports 14 (1), 3702 | 10.1038/s41598-023-50228-8 |
| Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people | Poisson J. et al. | 2024 | Immunity and Ageing 21 (1), 28 | 10.1186/s12979-024-00430-7 |
| Recent increase in atypical presentations of invasive meningococcal disease in France | Taha S. ; Deghmane A.E. ; Taha M.K. | 2024 | BMC Infectious Diseases 24 (1), 640 | 10.1186/s12879-024-09547-y |
| Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countries | Galmiche S. et al. | 2024 | BMC Global and Public Health 2 (1), 78 | 10.1186/s44263-024-00103-z |
| International congress on transposable elements (ICTE 2024) in Saint Malo: breaking down transposon waves and their impact | Lesage P. et al. | 2024 | Mobile DNA 15 (1), 25 | 10.1186/s13100-024-00334-9 |
| The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season | Bricout H. et al. | 2024 | Clinical Microbiology and Infection 30 (12), pp. 1592-1598 | 10.1016/j.cmi.2024.08.012 |
| New pedagogical tools for vaccine education: preparing future healthcare workers for the next pandemic | Gautier S. et al. | 2024 | BMC Medical Education 24 (1), 1314 | 10.1186/s12909-024-06274-5 |
| A look back at the Virology Departmental Days of the Institut Pasteur (Le Touquet, May 13-15, 2024) | González R. ; Koh C. ; Virlon B. ; Merkling S.H. ; Vartanian J.P. | 2024 | Journal of Molecular Cell Biology 16 (12), mjae052 | 10.1093/jmcb/mjae052 |
| Interplay between host humoral pattern recognition molecules controls undue immune responses against Aspergillus fumigatus | Dellière S. et al. | 2024 | Nature Communications 15 (1), 6966 | 10.1038/s41467-024-51047-9 |
| Natural language processing of multi-hospital electronic health records for public health surveillance of suicidality | Bey R. et al. | 2024 | Npj Mental Health Research 3 (1), 6 | 10.1038/s44184-023-00046-7 |
| Differential prevalence and risk factors for infection with coronaviruses in bats collected from Yunnan Province, China | Li R. et al. | 2024 | One Health 19, 100923 | 10.1016/j.onehlt.2024.100923 |
| Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts | Ruyssen-Witrand A. et al. | 2024 | Clinical and Experimental Rheumatology 42 (11), pp. 2141-2149 | 10.55563/clinexprheumatol/48440j |
| SARS-CoV-2 Infection in School Settings, Okinawa Prefecture, Japan, 2021–2022 | Takayama Y. et al. | 2024 | Emerging Infectious Diseases 30 (11), pp. 2343-2351 | 10.3201/eid3011.240638 |
| Genetic variations in Interferon-Induced with Helicase C Domain 1: Impact on COVID-19 risk and severity in the Moroccan population | Aqillouch S. et al. | 2024 | Human Immunology 85 (6), 111149 | 10.1016/j.humimm.2024.111149 |
| Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024 | Merdrignac L. et al. | 2024 | Influenza and Other Respiratory Viruses 18 (11), e70009 | 10.1111/irv.70009 |
| Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France | Sabaté-Elabbadi A. et al. | 2024 | Journal of Infection 89 (5), 106287 | 10.1016/j.jinf.2024.106287 |
| Integrating Contact Tracing Data to Enhance Outbreak Phylodynamic Inference: A Deep Learning Approach | Xie R. et al. | 2024 | Molecular Biology and Evolution 41 (11), msae232 | 10.1093/molbev/msae232 |
| The Bayesian Phylogenetic Bootstrap and its Application to Short Trees and Branches | Lemoine F. ; Gascuel O. | 2024 | Molecular Biology and Evolution 41 (11), msae238 | 10.1093/molbev/msae238 |
| The Effector Functions of Antibodies | Daëron M. | 2024 | Immunological Reviews 328 (1), pp. 6-12 | 10.1111/imr.13428 |
| Pediatric Hospitalizations and Emergency Department Visits Related to Mental Health Conditions and Self-Harm | Valtuille Z. et al. | 2024 | JAMA Network Open 7 (10), e2441874 | 10.1001/jamanetworkopen.2024.41874 |
| Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov) | Araujo-Chaveron L. ; Olivier C. ; Pellissier G. ; Bouvet E. ; Mueller J.E. | 2024 | Vaccine 42 (24), 126103 | 10.1016/j.vaccine.2024.07.004 |
| Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting | Jeger-Madiot R. et al. | 2024 | Journal of Experimental Medicine 221 (10), e20240289 | 10.1084/jem.20240289 |
| Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)] (Vaccine (2024) 42(19) (3931–3937), (S0264410X24006443), (10.1016/j.vaccine.2024.05.067)) | Laniece Delaunay C. et al. | 2024 | Vaccine 42 (23), 126089 | 10.1016/j.vaccine.2024.06.056 |
| The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients | Reyes-Ruiz J.M. et al. | 2024 | Journal of Clinical Medicine 13 (19), 5777 | 10.3390/jcm13195777 |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells | Beaumont E. ; Müller-Trutwin M. ; Huot N. | 2024 | Genes and Immunity 25 (5), pp. 443-445 | 10.1038/s41435-024-00284-5 |
| Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness—Valencia Region, Spain, 2010–2021 | Shirreff G. et al. | 2024 | Influenza and Other Respiratory Viruses 18 (10), e70017 | 10.1111/irv.70017 |
| Recent evolution of the epidemiology and burden of invasive meningococal disease | Taha S. ; Deghmane A.E. | 2024 | La Revue Du Praticien 74 (8), pp. s7-s10 | |
| Escape of SARS-CoV-2 Variants KP1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies | Planas D. et al. | 2024 | Pathogens and Immunity 10 (1), pp. 1-11 | 10.20411/pai.v10i1.752 |
| Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses | Paciello I. et al. | 2024 | Cell Reports 43 (9), 114645 | 10.1016/j.celrep.2024.114645 |
| Preschool-age children maintain a distinct memory CD4+ T cell and memory B cell response after SARS-CoV-2 infection | Manfroi B. et al. | 2024 | Science Translational Medicine 16 (765), eadl1997 | 10.1126/scitranslmed.adl1997 |
| Immune system adaptation during gender-affirming testosterone treatment | Lakshmikanth T. et al. | 2024 | Nature 633 (8028), pp. 155-164 | 10.1038/s41586-024-07789-z |
| SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency | Chan Y.H. et al. | 2024 | Journal of Experimental Medicine 221 (9), e20231725 | 10.1084/jem.20231725 |
| Multiple Mechanisms of Action of Sulfodyne®, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection | Romeo P.H. et al. | 2024 | Antioxidants 13 (9), 1083 | 10.3390/antiox13091083 |
| An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution | Subissi L. et al. | 2024 | Nature Medicine 30 (9), pp. 2400-2403 | 10.1038/s41591-024-02949-0 |
| Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS-CoV and SARS-CoV-2 | Hassanin A. et al. | 2024 | Molecular Ecology 33 (18), e17486 | 10.1111/mec.17486 |
| Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France | Perrey C. et al. | 2024 | Infectious Diseases Now 54 (6), 104943 | 10.1016/j.idnow.2024.104943 |
| Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia | Inizan C. et al. | 2024 | Plos Medicine 21 (9), e1004397 | 10.1371/journal.pmed.1004397 |
| Endolysosomal channel TMEM175 mediates antitoxin activity of DABMA | Wu Y. et al. | 2024 | FEBS Journal 291 (18), pp. 4142-4154 | 10.1111/febs.17242 |
| Understanding emerging and re-emerging viruses to facilitate pandemic preparedness | Zapatero-Belinchón F.J. ; Kumar P. ; Ott M. ; Schwartz O. ; Sigal A. | 2024 | Nature Microbiology 9 (9), pp. 2208-2211 | 10.1038/s41564-024-01789-5 |
| Systems vaccinology studies – achievements and future potential | Sugrue J.A. ; Duffy D. | 2024 | Microbes and Infection 26 (7), 105318 | 10.1016/j.micinf.2024.105318 |
| Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant | Euzen V. et al. | 2024 | International Journal of Antimicrobial Agents 64 (3), 107281 | 10.1016/j.ijantimicag.2024.107281 |
| Environmental variation and genetic diversity contribute to population differences in immune responses to SARS-CoV-2 and COVID-19 risk | Rotival M. ; Quintana-Murci L. | 2024 | Genes and Immunity 25 (4), pp. 338-340 | 10.1038/s41435-023-00249-0 |
| Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination | Durier C. et al. | 2024 | Infectious Diseases Now 54 (5), 104886 | 10.1016/j.idnow.2024.104886 |
| Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera | Eliadis P. et al. | 2024 | Vaccines 12 (8), 914 | 10.3390/vaccines12080914 |
| Routes of SARS-Cov2 transmission in the intensive care unit: A multicentric prospective study | Tandjaoui-Lambiotte Y. et al. | 2024 | Journal of Infection and Public Health 17 (8), 102454 | 10.1016/j.jiph.2024.05.042 |
| Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024 | Rodrigues C. et al. | 2024 | Eurosurveillance 29 (31), 2400459 | 10.2807/1560-7917.ES.2024.29.31.2400459 |
| Agreement between two real-time commercial PCR kits and an in-house real-time PCR for diagnosis of mucormycosis | Rafanomezantsoa L.C. et al. | 2024 | Microbiology Spectrum 12 (8) | 10.1128/spectrum.03585-23 |
| Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024 | Laniece Delaunay C. et al. | 2024 | Vaccine 42 (19), pp. 3931-3937 | 10.1016/j.vaccine.2024.05.067 |
| Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2 | Planchais C. et al. | 2024 | Iscience 27 (7), 110354 | 10.1016/j.isci.2024.110354 |
| The RBPome of influenza A virus NP-mRNA reveals a role for TDP-43 in viral replication | Dupont M. et al. | 2024 | Nucleic Acids Research 52 (12), pp. 7188-7210 | 10.1093/nar/gkae291 |
| COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 among Older Europeans | Laniece Delaunay C. et al. | 2024 | JAMA Network Open 7 (7), e2419258 | 10.1001/jamanetworkopen.2024.19258 |
| Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19 | Cavaillon J.M. ; Chousterman B.G. ; Skirecki T. | 2024 | Journal of Intensive Medicine 4 (3), pp. 326-340 | 10.1016/j.jointm.2024.01.001 |
| Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway | Mitri C. et al. | 2024 | Microbes and Infection 26 (5-6), 105354 | 10.1016/j.micinf.2024.105354 |
| High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors | Khan S. et al. | 2024 | Iscience 27 (6), 110019 | 10.1016/j.isci.2024.110019 |
| Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study | Funk A. et al. | 2024 | Clinical Infectious Diseases 78 (6), pp. 1522-1530 | 10.1093/cid/ciae069 |
| A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region | Huet K. et al. | 2024 | IJID Regions 11, 100373 | 10.1016/j.ijregi.2024.100373 |
| Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236 | Fujita S. et al. | 2024 | Ebiomedicine 104, 105181 | 10.1016/j.ebiom.2024.105181 |
| Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023 | Lazarus J.V. et al. | 2024 | Nature Medicine 30 (6), pp. 1559-1563 | 10.1038/s41591-024-02939-2 |
| The mission of COVARS: how to anticipate health risks within a "One Health" vision of the exposome | Autran B. et al. | 2024 | Medecine Sciences 40 (6-7), pp. 485-486 | 10.1051/medsci/2024098 |
| Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report | Nunes M.C. et al. | 2024 | Infectious Disease Modelling 9 (2), pp. 501-518 | 10.1016/j.idm.2024.02.008 |
| Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study | Jourdes A. et al. | 2024 | Clinical Microbiology and Infection 30 (6), pp. 764-771 | 10.1016/j.cmi.2024.02.023 |
| Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial | Thilly N. et al. | 2024 | JAMA Network Open 7 (5), e2411938 | 10.1001/jamanetworkopen.2024.11938 |
| Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France | Lièvre G. et al. | 2024 | Vaccine 42 (14), pp. 3288-3299 | 10.1016/j.vaccine.2024.04.024 |
| Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in Guinea | Grayo S. et al. | 2024 | Journal of Clinical Medicine 13 (10), 2965 | 10.3390/jcm13102965 |
| Geographic heterogeneity of SARS-CoV-2 circulation in Abidjan, Ivory Coast: a prospective study | Doumbia M. ; Sevede D. ; Kouakou V. ; Pineau P. | 2024 | Journal of Infection in Developing Countries 18 (5), pp. 679-686 | 10.3855/jidc.17675 |
| A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease | Nambulli S. et al. | 2024 | Journal of Virology 98 (5) | 10.1128/jvi.01762-23 |
| A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model | Brunet J. et al. | 2024 | Journal of Virology 98 (5) | 10.1128/jvi.01693-23 |
| Predicting consequences of COVID-19 control measure de-escalation on nosocomial transmission and mortality: a modelling study in a French rehabilitation hospital | Smith D.R.M. et al. | 2024 | Journal of Hospital Infection 147, pp. 47-55 | 10.1016/j.jhin.2024.02.020 |
| Emergence failure of early epidemics: A mathematical modeling approach | Breban R. | 2024 | Plos One 19 (5 May), e0301415 | 10.1371/journal.pone.0301415 |
| The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021 | Bita Fouda A.A. et al. | 2024 | Vaccines 12 (5), 461 | 10.3390/vaccines12050461 |
| AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor | Trepte P. et al. | 2024 | Molecular Systems Biology 20 (4), pp. 428-457 | 10.1038/s44320-024-00019-8 |
| Revealing the hidden interplay: The unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2, and influenza | Ghelfenstein-Ferreira T. ; Serris A. ; Salmona M. ; Lanternier F. ; Alanio A. | 2024 | Medical Mycology 62 (4), myae021 | 10.1093/mmy/myae021 |
| TMPRSS2 is the receptor of seasonal coronavirus HKU1 | Saunders N. ; Schwartz O. | 2024 | Medecine Sciences 40 (4), pp. 335-337 | 10.1051/medsci/2024034 |
| Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic | Valtuille Z. et al. | 2024 | JAMA Network Open 7 (4), e247965 | 10.1001/jamanetworkopen.2024.7965 |
| Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study | Hartner A.M. et al. | 2024 | Lancet Global Health 12 (4), pp. e563-e571 | 10.1016/S2214-109X(23)00603-4 |
| Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine | Cajander S. et al. | 2024 | Lancet Respiratory Medicine 12 (4), pp. 305-322 | 10.1016/S2213-2600(23)00330-2 |
| COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 | Delaunay C.L. et al. | 2024 | Eurosurveillance 29 (13), 2300403 | 10.2807/1560-7917.ES.2024.29.13.2300403 |
| Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants | Planas D. et al. | 2024 | Heliyon 10 (5), e27033 | 10.1016/j.heliyon.2024.e27033 |
| A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms | Ben Hamouda W. et al. | 2024 | Tropical Medicine and Infectious Disease 9 (3), 61 | 10.3390/tropicalmed9030061 |
| Comparative reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity data | Naffeti B. et al. | 2024 | IJID Regions 10, pp. 100-107 | 10.1016/j.ijregi.2023.11.011 |
| Use of Herbal Medicine in French Guiana: Influences and Challenges for Prevention Strategies in the Context of the COVID-19 Pandemic | Forsans G. et al. | 2024 | Journal of Herbal Medicine 44, 100848 | 10.1016/j.hermed.2024.100848 |
| Drug-induced hearing loss: Listening to the latest advances | Reynard P. ; Thai-Van H. | 2024 | Therapies 79 (2), pp. 283-295 | 10.1016/j.therap.2023.10.011 |
| Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021 | Beauté J. et al. | 2024 | Eurosurveillance 29 (7) | 10.2807/1560-7917.ES.2024.29.7.2300266 |
| Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study | Melenotte C. et al. | 2024 | Open Forum Infectious Diseases 11 (2), ofae012 | 10.1093/ofid/ofae012 |
| High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors | Tejiokem M.C. et al. | 2024 | Influenza and Other Respiratory Viruses 18 (2), e13239 | 10.1111/irv.13239 |
| SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency | Zhang L. et al. | 2024 | Cell 187 (3), pp. 596-608.e17 | 10.1016/j.cell.2023.12.025 |
| Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment | Thai-Van H. ; Bagheri H. ; Valnet-Rabier M.B. | 2024 | Vaccines 12 (2), 181 | 10.3390/vaccines12020181 |
| Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022 | Rakover A. et al. | 2024 | BMC Public Health 24 (1), pp. 325 | 10.1186/s12889-024-17772-y |
| Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023 | Jeworowski L.M. et al. | 2024 | Eurosurveillance 29 (2) | 10.2807/1560-7917.ES.2024.29.2.2300740 |
| Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants | Coutant F. et al. | 2024 | Emerging Microbes and Infections 13 (1), 2307510 | 10.1080/22221751.2024.2307510 |
| Risk Factors for Community and Intrahousehold Transmission of SARS-CoV-2: Modeling in a Nationwide French Population-Based Cohort Study, the EpiCoV Study | Novelli S. et al. | 2024 | American Journal of Epidemiology 193 (1), pp. 134-148 | 10.1093/aje/kwad174 |
| High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1 | Bolland W. et al. | 2024 | Journal of Virology 98 (1) | 10.1128/jvi.01351-23 |
| A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasm | Neitthoffer B. et al. | 2024 | Journal of Biological Chemistry 300 (1), 105575 | 10.1016/j.jbc.2023.105575 |
| Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period | Schmutz M. et al. | 2024 | Frontiers in Immunology 15, 1445610 | 10.3389/fimmu.2024.1445610 |
| In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients | Benotmane I. et al. | 2024 | Transplant International 37, 13272 | 10.3389/ti.2024.13272 |
| Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis | Lingas G. et al. | 2024 | Clinical Pharmacology and Therapeutics 115 (1), pp. 86-94 | 10.1002/cpt.3069 |
| Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality | Uetz P. et al. | 2024 | Frontiers in Bioengineering and Biotechnology 12, 1329018 | 10.3389/fbioe.2024.1329018 |
| Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children | Bastard P. et al. | 2024 | Journal of Experimental Medicine 221 (2), e20231353 | 10.1084/jem.20231353 |
| Feasibility, Acceptability, Satisfaction, and Challenges of an mHealth App (e-ASCov) for Community-Based COVID-19 Screening by Community Health Workers in Rwanda: Mixed Methods Study | Omorou A.Y. et al. | 2024 | Jmir Mhealth and Uhealth 12, e50745 | 10.2196/50745 |
| Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10 | Lapierre L.A. et al. | 2024 | Cells 13 (2), 126 | 10.3390/cells13020126 |
| Viral Zoonoses: Interactions and Factors Driving Virus Transmission | Ermonval M. ; Morand S. | 2024 | Viruses 16 (1), 9 | 10.3390/v16010009 |
| Transient reemergence of Bordetella parapertussis in France in 2022 | Bouchez V. et al. | 2024 | Journal of Medical Microbiology 73 (7), 001843 | 10.1099/jmm.0.001843 |
| The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa | Osaigbovo I.I. et al. | 2024 | Medical Mycology 62 (1), myad141 | 10.1093/mmy/myad141 |
| Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance Network | Rybak A. et al. | 2024 | Pediatric Infectious Disease Journal 43 (1), pp. 74-83 | 10.1097/INF.0000000000004134 |
| Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs | Bastard P. et al. | 2023 | Science Immunology 8 (90), eabp8966 | 10.1126/sciimmunol.abp8966 |
| An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike | Chêne A. et al. | 2023 | Journal of Infectious Diseases 228 (12), pp. 1675-1679 | 10.1093/infdis/jiad329 |
| Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2 | Bhargava A. et al. | 2023 | Iscience 26 (12), 108449 | 10.1016/j.isci.2023.108449 |
| TMPRSS2 is a functional receptor for human coronavirus HKU1 | Saunders N. et al. | 2023 | Nature 624 (7990), pp. 207-214 | 10.1038/s41586-023-06761-7 |
| Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants | de Melo G.D. et al. | 2023 | Nature Communications 14 (1), 4485 | 10.1038/s41467-023-40228-7 |
| A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach | Abatematteo F.S. et al. | 2023 | Scientific Reports 13 (1), 12798 | 10.1038/s41598-023-39662-w |
| Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial | Leblanc J. et al. | 2023 | Plos Medicine 20 (12), e1004317 | 10.1371/journal.pmed.1004317 |
| An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern | Perez-Romero C.A. et al. | 2023 | Scientific Reports 13 (1), 15782 | 10.1038/s41598-023-42348-y |
| Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case–control study | Galmiche S. et al. | 2023 | BMC Public Health 23 (1), 1240 | 10.1186/s12889-023-16144-2 |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells | Huot N. et al. | 2023 | Nature Immunology 24 (12), pp. 2068-2079 | 10.1038/s41590-023-01661-4 |
| Author Correction: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants (Nature Communications, (2023), 10.1038/s41467-023-40228-7) | de Melo G.D. et al. | 2023 | Nature Communications 14 (1), 8024 | 10.1038/s41467-023-42800-7 |
| Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1 | Lassaunière R. et al. | 2023 | Lancet Infectious Diseases 23 (12), pp. e509-e510 | 10.1016/S1473-3099(23)00682-5 |
| Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France | Paireau J. et al. | 2023 | BMC Infectious Diseases 23 (1), 190 | 10.1186/s12879-023-08106-1 |
| Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study | Tan-Lhernould L. et al. | 2023 | BMC Medicine 21 (1), 426 | 10.1186/s12916-023-03119-8 |
| Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis | Lafay C. et al. | 2023 | Journal of Pediatrics 263, 113682 | 10.1016/j.jpeds.2023.113682 |
| Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies | Planas D. et al. | 2023 | Nature Communications 14 (1), 824 | 10.1038/s41467-023-36561-6 |
| Impact of influenza immunity on the mortality among older adults hospitalized with COVID-19: a retrospective cohort study | Coulongeat M. et al. | 2023 | Clinical and Experimental Medicine 23 (8), pp. 4955-4965 | 10.1007/s10238-023-01203-0 |
| Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemic | Loedy N. et al. | 2023 | BMC Public Health 23 (1), 1298 | 10.1186/s12889-023-16193-7 |
| Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets | Haas K.M. et al. | 2023 | Nature Communications 14 (1), 6030 | 10.1038/s41467-023-41442-z |
| Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France | Roux J. ; Massonnaud C.R. ; Colizza V. ; Cauchemez S. ; Crépey P. | 2023 | Scientific Reports 13 (1), 1834 | 10.1038/s41598-023-28687-w |
| Emotional and behavioral changes in French children during the COVID-19 pandemic: a retrospective study | Landman B. et al. | 2023 | Scientific Reports 13 (1), 2003 | 10.1038/s41598-023-29193-9 |
| The rapid rebound of invasive meningococcal disease in France at the end of 2022 | Taha S. et al. | 2023 | Journal of Infection and Public Health 16 (12), pp. 1954-1960 | 10.1016/j.jiph.2023.10.001 |
| Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study | Contejean A. et al. | 2023 | American Journal of Hematology 98 (12), pp. E349-E353 | 10.1002/ajh.27071 |
| Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Oudin Doglioni D. et al. | 2023 | Scientific Reports 13 (1), 19895 | 10.1038/s41598-023-46864-9 |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency | Le Voyer T. et al. | 2023 | Nature 623 (7988), pp. 803-813 | 10.1038/s41586-023-06717-x |
| How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review | Smith D.R.M. et al. | 2023 | Journal of Hospital Infection 141, pp. 132-141 | 10.1016/j.jhin.2023.07.028 |
| Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022 | Meslé M.M.I. et al. | 2023 | Influenza and Other Respiratory Viruses 17 (11), e13219 | 10.1111/irv.13219 |
| The Wood equation allows consistent fitting of individual antibody-response profiles of Zika virus or SARS-CoV-2 infected patients | Denis J. et al. | 2023 | Heliyon 9 (11), e21945 | 10.1016/j.heliyon.2023.e21945 |
| A synthetic delivery vector for mucosal vaccination | Billet A. et al. | 2023 | Biomaterials 302, 122298 | 10.1016/j.biomaterials.2023.122298 |
| Fast and Accurate Maximum‑Likelihood Estimation of Multi‑Type Birth–Death Epidemiological Models from Phylogenetic Trees | Zhukova A. ; Hecht F. ; Maday Y. ; Gascuel O. | 2023 | Systematic Biology 72 (6), pp. 1387-1402 | 10.1093/sysbio/syad059 |
| Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity | Jones T. et al. | 2023 | ACS Omega 8 (43), pp. 40817-40822 | 10.1021/acsomega.3c05900 |
| Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients | Bruel T. et al. | 2023 | Med 4 (10), pp. 664-667 | 10.1016/j.medj.2023.07.007 |
| SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review | Wiedenmann M. et al. | 2023 | BMJ Open 13 (10), e072280 | 10.1136/bmjopen-2023-072280 |
| SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo | Mahé D. et al. | 2023 | Journal of Virology 97 (10) | 10.1128/jvi.01104-23 |
| Monitoring the reproductive number of COVID-19 in France: Comparative estimates from three datasets | Bonaldi C. ; Fouillet A. ; Sommen C. ; Lévy-Bruhl D. ; Paireau J. | 2023 | Plos One 18 (10 October), e0293585 | 10.1371/journal.pone.0293585 |
| Neuroimmunology of rabies: New insights into an ancient disease | Bastos V. et al. | 2023 | Journal of Medical Virology 95 (10), e29042 | 10.1002/jmv.29042 |
| A rapid qualitative methods assessment and reporting tool for epidemic response as the outcome of a rapid review and expert consultation | Dong D. et al. | 2023 | Plos Global Public Health 3 (10 October), e0002320 | 10.1371/journal.pgph.0002320 |
| Neutralization, effector function and immune imprinting of Omicron variants | Addetia A. et al. | 2023 | Nature 621 (7979), pp. 592-601 | 10.1038/s41586-023-06487-6 |
| Risk of SARS-CoV-2 Infection among Households with Children in France, 2020-2022 | Galmiche S. et al. | 2023 | JAMA Network Open 6 (9), pp. E2334084 | 10.1001/jamanetworkopen.2023.34084 |
| SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals | Sokal A. et al. | 2023 | Immunity 56 (9), pp. 2137-2151.e7 | 10.1016/j.immuni.2023.07.007 |
| Dissecting human population variation in single-cell responses to SARS-CoV-2 | Aquino Y. et al. | 2023 | Nature 621 (7977), pp. 120-128 | 10.1038/s41586-023-06422-9 |
| A second update on mapping the human genetic architecture of COVID-19 | Kanai M. et al. | 2023 | Nature 621 (7977), pp. E7-E26 | 10.1038/s41586-023-06355-3 |
| Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication | Le Chevalier F. et al. | 2023 | Microbes and Infection 25 (7), 105142 | 10.1016/j.micinf.2023.105142 |
| Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021 | Ochida N. et al. | 2023 | IJID Regions 8, pp. 64-70 | 10.1016/j.ijregi.2023.06.004 |
| Lessons from COVID-19 for rescalable data collection | Bhatia S. et al. | 2023 | Lancet Infectious Diseases 23 (9), pp. e383-e388 | 10.1016/S1473-3099(23)00121-4 |
| Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium | Shaw D. et al. | 2023 | Lancet Digital Health 5 (9), pp. e582-e593 | 10.1016/S2589-7500(23)00108-5 |
| The Many Hosts of Mycobacteria 9 (MHM9): A conference report | Klever A.M. et al. | 2023 | Tuberculosis 142, 102377 | 10.1016/j.tube.2023.102377 |
| Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults | Araujo-Chaveron L. et al. | 2023 | Vaccine 41 (37), pp. 5412-5423 | 10.1016/j.vaccine.2023.07.002 |
| RESEARCH ARTICLE Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic | Wasniewski M. et al. | 2023 | Plos One 18 (8 August), e0290444 | 10.1371/journal.pone.0290444 |
| Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2 | Clairon Q. et al. | 2023 | Plos Computational Biology 19 (8 August), e1011282 | 10.1371/journal.pcbi.1011282 |
| Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates | Marc A. et al. | 2023 | Plos Computational Biology 19 (8 August), e1010721 | 10.1371/journal.pcbi.1010721 |
| During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant | Cavaillon J.M. | 2023 | Clinical Reviews in Allergy and Immunology 65 (2), pp. 183-187 | 10.1007/s12016-023-08965-1 |
| JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study | Frémond M.L. et al. | 2023 | Journal of Clinical Immunology 43 (6), pp. 1436-1447 | 10.1007/s10875-023-01500-z |
| Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 | Tsui J.L.H. et al. | 2023 | Science 381 (6655), pp. 336-343 | 10.1126/science.adg6605 |
| Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics | Broketa M. et al. | 2023 | Jci Insight 8 (13), e166602 | 10.1172/JCI.INSIGHT.166602 |
| Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysis | Valtuille Z. et al. | 2023 | Eclinicalmedicine 61, 102078 | 10.1016/j.eclinm.2023.102078 |
| Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome | Schön M. et al. | 2023 | European Journal of Medical Genetics 66 (7), 104754 | 10.1016/j.ejmg.2023.104754 |
| Animal Toxins: A Historical Outlook at the Institut Pasteur of Paris | Popoff M.R. ; Faure G. ; Legout S. ; Ladant D. | 2023 | Toxins 15 (7), 462 | 10.3390/toxins15070462 |
| Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021 | Woudenberg T. et al. | 2023 | Eurosurveillance 28 (25), A4 | 10.2807/1560-7917.ES.2023.28.25.2200681 |
| Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study | Smith D.R.M. ; Shirreff G. ; Temime L. ; Opatowski L. | 2023 | Plos Medicine 20 (6 June), e1004240 | 10.1371/journal.pmed.1004240 |
| Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique | Gbaguidi G.N. et al. | 2023 | Infectious Diseases Now 53 (4), 104690 | 10.1016/j.idnow.2023.104690 |
| SARS-CoV-2 E and 3a Proteins Are Inducers of Pannexin Currents | Oliveira-Mendes B.B.R. et al. | 2023 | Cells 12 (11), 1474 | 10.3390/cells12111474 |
| Emergence, spread and characterisation of the SARSCoV- 2 variant B.1.640 circulating in France, October 2021 to February 2022 | Picard G. et al. | 2023 | Eurosurveillance 28 (22) | 10.2807/1560-7917.ES.2023.28.22.2200671 |
| Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis | Galmiche S. ; Charmet T. ; Mailles A. ; Fontanet A. | 2023 | Infection 51 (3), pp. 793-795 | 10.1007/s15010-022-01951-3 |
| SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study | Galmiche S. et al. | 2023 | Lancet Microbe 4 (6), pp. e409-e417 | 10.1016/S2666-5247(23)00005-8 |
| Severe Bacterial Infection Initially Misdiagnosed as MIS-C: Caution Needed | Stanzelova A. et al. | 2023 | Pediatric Infectious Disease Journal 42 (6), pp. E201-E203 | 10.1097/INF.0000000000003896 |
| Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model | Hérate C. et al. | 2023 | Heliyon 9 (6), e16664 | 10.1016/j.heliyon.2023.e16664 |
| Analyzing the Geometry and Dynamics of Viral Structures: A Review of Computational Approaches Based on Alpha Shape Theory, Normal Mode Analysis, and Poisson–Boltzmann Theories | Hsieh Y.C. ; Delarue M. ; Orland H. ; Koehl P. | 2023 | Viruses 15 (6), 1366 | 10.3390/v15061366 |
| Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children | Avramescu M. et al. | 2023 | Kidney International 103 (6), pp. 1193-1198 | 10.1016/j.kint.2023.02.028 |
| Community engagement: learning from low-income countries | Kutalek R. ; Ahmed S.M. ; Kaawa-Mafigiri D. ; Giles-Vernick T. | 2023 | Lancet 401 (10390), pp. 1767-1768 | 10.1016/S0140-6736(23)00568-8 |
| Highlights from the Inaugural HIV Reservoirs and Immune Control Conference, October 1st–4th 2023, Malahide Ireland | O’Doherty U. ; Martinez-Picado J. ; Sáez-Cirión A. | 2023 | Pathogens and Immunity 8 (1), pp. 161-169 | 10.20411/pai.v8i1.653 |
| SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022 | Supplisson O. et al. | 2023 | Eurosurveillance 28 (18) | 10.2807/1560-7917.ES.2023.28.18.2200781 |
| A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field | Ceruti A. et al. | 2023 | Journal of Clinical Virology 162, 105422 | 10.1016/j.jcv.2023.105422 |
| Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia | García-García A. et al. | 2023 | Journal of Experimental Medicine 220 (5), e20220170 | 10.1084/jem.20220170 |
| Sick leave due to COVID-19 during the first pandemic wave in France, 2020 | Smith D.R.M. et al. | 2023 | Occupational and Environmental Medicine 80 (5), pp. 268-272 | 10.1136/oemed-2022-108451 |
| Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: Data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries | Machado P.M. et al. | 2023 | Annals of the Rheumatic Diseases 82 (5), pp. 698-709 | 10.1136/ard-2022-223499 |
| SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021 | Gallian P. et al. | 2023 | Iscience 26 (4), 106222 | 10.1016/j.isci.2023.106222 |
| Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages | Touret F. et al. | 2023 | Iscience 26 (4), 106413 | 10.1016/j.isci.2023.106413 |
| SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19 | Temmam S. et al. | 2023 | EMBO Reports 24 (4), e56055 | 10.15252/embr.202256055 |
| How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? | Pons S. et al. | 2023 | Stem Cell Reviews and Reports 19 (3), pp. 585-600 | 10.1007/s12015-022-10477-y |
| Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines | Fraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D.H. | 2023 | Trends in Molecular Medicine 29 (4), pp. 255-267 | 10.1016/j.molmed.2023.01.003 |
| Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings | Benabdessalem C. et al. | 2023 | Diagnostic Microbiology and Infectious Disease 105 (4), 115903 | 10.1016/j.diagmicrobio.2023.115903 |
| Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation | Philippe A. et al. | 2023 | Archives of Cardiovascular Diseases 116 (4), pp. 183-191 | 10.1016/j.acvd.2023.01.006 |
| New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic | Teirlinck A.C. et al. | 2023 | European Respiratory Journal 61 (4), 2201569 | 10.1183/13993003.01569-2022 |
| Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France | Tamandjou Tchuem C.R. et al. | 2023 | Vaccine 41 (13), pp. 2280-2288 | 10.1016/j.vaccine.2023.02.062 |
| Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants | Chauvin C. et al. | 2023 | Iscience 26 (3), 106124 | 10.1016/j.isci.2023.106124 |
| A specific molecular signature in SARS-CoV-2–infected kidney biopsies | Isnard P. et al. | 2023 | Jci Insight 8 (5), e165192 | 10.1172/jci.insight.165192 |
| Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection | Fraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D. ; Müller-Trutwin M. | 2023 | European Respiratory Review 32 (167), 220197 | 10.1183/16000617.0197-2022 |
| Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro | Rousseaud A. et al. | 2023 | Nitric Oxide Biology and Chemistry 132, pp. 27-33 | 10.1016/j.niox.2023.01.004 |
| Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants | Vaid R. et al. | 2023 | Genome Research 33 (3), pp. 299-313 | 10.1101/gr.276407.121 |
| The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps | Wong A. et al. | 2023 | Plos Pathogens 19 (3), e1011167 | 10.1371/journal.ppat.1011167 |
| Prognosis value of pupillometry in COVID-19 patients admitted in intensive care unit | Daniel M. et al. | 2023 | Autonomic Neuroscience Basic and Clinical 245, 103057 | 10.1016/j.autneu.2022.103057 |
| Lentiviral Vectors as a Vaccine Platform against Infectious Diseases | Nemirov K. et al. | 2023 | Pharmaceutics 15 (3), 846 | 10.3390/pharmaceutics15030846 |
| On the risk of further excluding outcast patient populations in South America | Ruiz E. et al. | 2023 | Annals of Hepatology 28 (2), 100901 | 10.1016/j.aohep.2023.100901 |
| Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children | Lee D. et al. | 2023 | Science 379 (6632), eabo3627 | 10.1126/science.abo3627 |
| Drawing a pandemic vulnerabilities' map: The SoNAR-global Vulnerabilities Assessment digital and its output | Vaccaro C. et al. | 2023 | Frontiers in Sociology 8, 1127647 | 10.3389/fsoc.2023.1127647 |
| Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses | Said E.A. ; Ancuta P. ; Routy J.P. ; Vartanian J.P. ; Al-Jabri A.A. | 2023 | Frontiers in Immunology 14, 1137399 | 10.3389/fimmu.2023.1137399 |
| Managing sources of error during pandemics | Cauchemez S. ; Bosetti P. ; Cowling B.J. | 2023 | Science 379 (6631), pp. 437-439 | 10.1126/science.add3173 |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria | Rosain J. et al. | 2023 | Cell 186 (3), pp. 621-645.e33 | 10.1016/j.cell.2022.12.038 |
| Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia | Kharroubi G. et al. | 2023 | Archives of Virology 168 (2), 69 | 10.1007/s00705-022-05636-y |
| Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication | Nakajima S. et al. | 2023 | Viruses 15 (2), 452 | 10.3390/v15020452 |
| Renal arcuate vein thrombosis-induced acute kidney injury: a rare multiple-Hit-mediated disease | Pardinhas C. et al. | 2023 | Clinical Kidney Journal 16 (2), pp. 367-373 | 10.1093/ckj/sfac244 |
| Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment | Sicsic J. ; Blondel S. ; Chyderiotis S. ; Langot F. ; Mueller J.E. | 2023 | European Journal of Health Economics 24 (1), pp. 81-98 | 10.1007/s10198-022-01454-w |
| Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France | Pérot P. et al. | 2023 | Emerging Infectious Diseases 29 (2), pp. 286-293 | 10.3201/eid2902.221468 |
| Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: A French multi-centered prospective observational study | Dobre D. et al. | 2023 | Psychological Medicine 53 (2), pp. 342-350 | 10.1017/S0033291721001537 |
| Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors | Hassan H. et al. | 2023 | Rsc Medicinal Chemistry 14 (3), pp. 507-519 | 10.1039/d2md00149g |
| Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients | Heyerdahl L.W. et al. | 2023 | Vaccine 41 (4), pp. 883-891 | 10.1016/j.vaccine.2022.10.048 |
| Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination | Sokal A. et al. | 2023 | Journal of Experimental Medicine 220 (1), e20220258 | 10.1084/jem.20220258 |
| Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021 | Su Y.C.F. et al. | 2023 | Virus Evolution 9 (1), veac121 | 10.1093/ve/veac121 |
| A proteome-scale map of the SARS-CoV-2–human contactome | Kim D.K. et al. | 2023 | Nature Biotechnology 41 (1), pp. 140-149 | 10.1038/s41587-022-01475-z |
| Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement? | Boluda S. et al. | 2023 | Free Neuropathology 4, 1 | 10.17879/freeneuropathology-2023-4584 |
| Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders | Denis J. et al. | 2023 | Frontiers in Immunology 14, 1140714 | 10.3389/fimmu.2023.1140714 |
| Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies | Ferjancic Z. et al. | 2023 | Journal of Enzyme Inhibition and Medicinal Chemistry 39 (1), 2289007 | 10.1080/14756366.2023.2289007 |
| Divergent adaptive immune responses define two types of long COVID | Kervevan J. et al. | 2023 | Frontiers in Immunology 14, 1221961 | 10.3389/fimmu.2023.1221961 |
| New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants | Marchini A. et al. | 2023 | Viruses 15 (1), 206 | 10.3390/v15010206 |
| Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study | Bougeard S. et al. | 2023 | Jmir Public Health and Surveillance 9 (1), e46898 | 10.2196/46898 |
| SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1 | Zhou B. et al. | 2023 | Emerging Microbes and Infections 12 (2), 2245921 | 10.1080/22221751.2023.2245921 |
| Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters | Vesin B. et al. | 2023 | Vaccines 11 (1), 12 | 10.3390/vaccines11010012 |
| The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule | Colson P. et al. | 2023 | Journal of Medical Virology 95 (1), e28102 | 10.1002/jmv.28102 |
| One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance | Boukli N. et al. | 2023 | Frontiers in Medicine 10, 1161268 | 10.3389/fmed.2023.1161268 |
| About Morgan Jouvenet's article: "Science and society in the time of the COVID-19 pandemic: Research on the natural origins of SARS-CoV-2" | Bontems F. | 2023 | Natures Sciences Societes 365 (6455) | 10.1051/nss/2023002 |
| Statistical Analysis of Post-Translational Modifications Quantified by Label-Free Proteomics Across Multiple Biological Conditions with R: Illustration from SARS-CoV-2 Infected Cells | Giai Gianetto Q. | 2023 | Methods in Molecular Biology 2426, pp. 267-302 | 10.1007/978-1-0716-1967-4_12 |
| Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna | Brault A. et al. | 2023 | Lancet Regional Health Western Pacific 30, 100634 | 10.1016/j.lanwpc.2022.100634 |
| African countries from the Pasteur Network reexamine their syndromic sentinel surveillance system associated with household contact within the AFROSCREEN program | Tejiokem M.C. et al. | 2023 | Frontiers in Public Health 11, 1292435 | 10.3389/fpubh.2023.1292435 |
| Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? | Plocque A. et al. | 2023 | Drugs 83 (1), pp. 1-36 | 10.1007/s40265-022-01803-2 |
| Main modulators of COVID-19 epidemic in sub-Saharan Africa | Zinsou B.E. et al. | 2023 | Heliyon 9 (1), e12727 | 10.1016/j.heliyon.2022.e12727 |
| Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants (Frontiers in Immunology, (2021), 12, (761250), 10.3389/fimmu.2021.761250) | Vanhove B. et al. | 2023 | Frontiers in Immunology 14, 1208705 | 10.3389/fimmu.2023.1208705 |
| Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination:Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database | Thai-Van H. et al. | 2023 | Jmir Public Health and Surveillance 9, e45263 | 10.2196/45263 |
| More than one crisis: COVID-19 response actors navigating multi-dimensional crises in Flanders, Belgium | Kattumana T. et al. | 2023 | Critical Public Health 33 (5), pp. 566-578 | 10.1080/09581596.2023.2240480 |
| Impact and mitigation of sampling bias to determine viral spread: Evaluating discrete phylogeography through CTMC modeling and structured coalescent model approximations | Layan M. et al. | 2023 | Virus Evolution 9 (1), vead010 | 10.1093/ve/vead010 |
| Effect of the COVID-19 pandemic on emergency gastrointestinal surgery in a university hospital in Paris over three consecutive years: A cohort study | Paktoris H. ; Montravers P. ; Rebibo L. ; Ribeiro L. ; Gouel-Chéron A. | 2023 | European Journal of Anaesthesiology 40 (1), pp. 60-63 | 10.1097/EJA.0000000000001737 |
| Messenger RNA (mRNA) vaccination, model of transition from basic biology to medicine | Sansonetti P.J. | 2023 | Comptes Rendus Biologies 346, pp. 69-74 | 10.5802/crbiol.129 |
| Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections | Tsang T.K. et al. | 2023 | Proceedings of the National Academy of Sciences of the United States of America 120 (33), e2304750120 | 10.1073/pnas.2304750120 |
| Parallel vaccine discourses in Guinea: ‘grounding’ social listening for a non-hegemonic global health | Heyerdahl L.W. et al. | 2023 | Critical Public Health 33 (5), pp. 579-593 | 10.1080/09581596.2023.2245964 |
| Antibodies as drugs—a Keystone Symposia report | Cable J. et al. | 2023 | Annals of the New York Academy of Sciences 1519 (1), pp. 153-166 | 10.1111/nyas.14915 |
| Epigenetic and gene regulatory functions of small RNAs | Cecere G. | 2023 | Comptes Rendus Biologies 346 | 10.5802/crbiol.131 |
| Embracing context: Lessons from designing a dialogue-based intervention to address vaccine hesitancy | Nguyen T.T. et al. | 2023 | Frontiers in Public Health 11, 1069199 | 10.3389/fpubh.2023.1069199 |
| Umbrella Data Management Plans to Integrate FAIR Data : Lessons From the ISIDORe and BY-COVID Consortia for Pandemic Preparedness | David R. et al. | 2023 | Data Science Journal 22, 35 | 10.5334/dsj-2023-035 |
| Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies | Bruel T. et al. | 2022 | Cell Reports Medicine 3 (12), 100850 | 10.1016/j.xcrm.2022.100850 |
| Louis Pasteur, COVID-19, and the social challenges of epidemics | Giles-Vernick T. ; Cheah P.Y. ; Matta G. ; Lima N.T. | 2022 | Lancet 400 (10369), pp. 2166-2168 | 10.1016/S0140-6736(22)02488-6 |
| Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection | Planas D. et al. | 2022 | Med 3 (12), pp. 838-847.e3 | 10.1016/j.medj.2022.09.010 |
| Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen | Mac Kain A. et al. | 2022 | Nature Communications 13 (1), 2442 | 10.1038/s41467-022-30134-9 |
| Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study | Rosello A. et al. | 2022 | BMC Infectious Diseases 22 (1), 324 | 10.1186/s12879-022-07268-8 |
| Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis | Pipoli da Fonseca J. et al. | 2022 | Scientific Reports 12 (1), 19274 | 10.1038/s41598-022-23422-3 |
| Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France | Bosetti P. et al. | 2022 | BMC Medicine 20 (1), 33 | 10.1186/s12916-022-02235-1 |
| Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk | Smith D.R.M. et al. | 2022 | Nature Communications 13 (1), 236 | 10.1038/s41467-021-27845-w |
| Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years | Durier C. et al. | 2022 | Scientific Reports 12 (1), 20373 | 10.1038/s41598-022-24409-w |
| Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian example | Jijón S. et al. | 2022 | Scientific Reports 12 (1), 19773 | 10.1038/s41598-022-23428-x |
| Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity | Smith N. et al. | 2022 | Nature Communications 13 (1), 7254 | 10.1038/s41467-022-34895-1 |
| Database of SARS-CoV-2 and coronaviruses kinetics relevant for assessing persistence in food processing plants | Luong N.D.M. et al. | 2022 | Scientific Data 9 (1), 654 | 10.1038/s41597-022-01763-y |
| Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model | Haschka T. ; Vergu E. ; Roche B. ; Poletto C. ; Opatowski L. | 2022 | BMC Infectious Diseases 22 (1), 815 | 10.1186/s12879-022-07821-5 |
| IMPACTS OF THE COVID-19 PANDEMIC ON CHILDREN AND ADOLESCENTS | Trebossen V. ; Khoury É. ; Delorme R. | 2022 | Revue Du Praticien 72 (10), pp. 1067-1070 | |
| Antibody escape and global spread of SARS-CoV-2 lineage A.27 | Kaleta T. et al. | 2022 | Nature Communications 13 (1), 1152 | 10.1038/s41467-022-28766-y |
| Temporary ICUs during the COVID-19 pandemic first wave: description of the cohort at a French centre | Zappella N. et al. | 2022 | BMC Anesthesiology 22 (1), 310 | 10.1186/s12871-022-01845-9 |
| The effect of COVID certificates on vaccine uptake, health outcomes, and the economy | Oliu-Barton M. et al. | 2022 | Nature Communications 13 (1), 3942 | 10.1038/s41467-022-31394-1 |
| MEPSi: A tool for simulating tomograms of membrane-embedded proteins | Rodríguez de Francisco B. ; Bezault A. ; Xu X.P. ; Hanein D. ; Volkmann N. | 2022 | Journal of Structural Biology 214 (4), 107921 | 10.1016/j.jsb.2022.107921 |
| Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report | Cable J. et al. | 2022 | Annals of the New York Academy of Sciences 1518 (1), pp. 209-225 | 10.1111/nyas.14898 |
| Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Faucher B. et al. | 2022 | Nature Communications 13 (1), 1414 | 10.1038/s41467-022-29015-y |
| Viruses to rescue health: Vaccination | Tangy F. ; Tournier J.N. | 2022 | Medecine Sciences 38 (12), pp. 1052-1060 | 10.1051/medsci/2022168 |
| Meningococcal disease in North America: Updates from the Global Meningococcal Initiative | Asturias E.J. et al. | 2022 | Journal of Infection 85 (6), pp. 611-622 | 10.1016/j.jinf.2022.10.022 |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages | Park Y.J. et al. | 2022 | Science 378 (6620), pp. 619-627 | 10.1126/science.adc9127 |
| The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses | Bonaventure B. et al. | 2022 | EMBO Reports 23 (11), e54061 | 10.15252/embr.202154061 |
| Dynamics of SARS-CoV-2 lineages in French Guiana in 2020–2021: 4 epidemic waves with cross-influences from Europe and South America | Miliu A. et al. | 2022 | Infection Genetics and Evolution 105, 105370 | 10.1016/j.meegid.2022.105370 |
| Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2 | Planchais C. et al. | 2022 | Protein Science 31 (11), e4447 | 10.1002/pro.4447 |
| SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study | Belan M. et al. | 2022 | Clinical Microbiology and Infection 28 (11), pp. 1471-1476 | 10.1016/j.cmi.2022.05.038 |
| Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers | Sarrigeorgiou I. et al. | 2022 | Plos One 17 (11 November), e0277827 | 10.1371/journal.pone.0277827 |
| Upward trend for “Microbes and infection” | Dussurget O. ; Ojcius D.M. | 2022 | Microbes and Infection 24 (8), 105057 | 10.1016/j.micinf.2022.105057 |
| The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4 | Parodi L. et al. | 2022 | Genetics in Medicine 24 (11), pp. 2308-2317 | 10.1016/j.gim.2022.07.023 |
| The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling | Laplantine E. et al. | 2022 | Iscience 25 (10), 105066 | 10.1016/j.isci.2022.105066 |
| Rapid investigation of BA.4/BA.5 cases in France | Kouamen A.C. et al. | 2022 | Frontiers in Public Health 10, 1006631 | 10.3389/fpubh.2022.1006631 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance | Tegally H. et al. | 2022 | Science 378 (6615), eabq5358 | 10.1126/science.abq5358 |
| Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age children | Delaunay-Moisan A. et al. | 2022 | Environmental Microbiology 24 (10), pp. 4725-4737 | 10.1111/1462-2920.16151 |
| The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants | Gellenoncourt S. et al. | 2022 | Journal of Virology 96 (19) | 10.1128/jvi.01301-22 |
| No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022) | Fourgeaud J. et al. | 2022 | Journal of Infection 85 (4), pp. 436-480 | 10.1016/j.jinf.2022.06.019 |
| An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa | Vesin B. et al. | 2022 | Molecular Therapy 30 (9), pp. 2984-2997 | 10.1016/j.ymthe.2022.04.016 |
| Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control | Mura M. ; Simon F. ; Pommier de Santi V. ; Tangy F. ; Tournier J.N. | 2022 | Vaccines 10 (9), 1555 | 10.3390/vaccines10091555 |
| Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: The 2020–2021 and 2021–2022 seasons | Vaux S. et al. | 2022 | Infectious Diseases Now 52 (6), pp. 374-378 | 10.1016/j.idnow.2022.06.003 |
| Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study | Bruel T. et al. | 2022 | Eclinicalmedicine 51, 101576 | 10.1016/j.eclinm.2022.101576 |
| Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al | Ouldali N. et al. | 2022 | Annals of the Rheumatic Diseases 81 (9), e160 | 10.1136/annrheumdis-2020-218614 |
| Postscript: A pandemic read on African health and environmental histories | Giles-Vernick T. | 2022 | Health and Place 77, 102846 | 10.1016/j.healthplace.2022.102846 |
| Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors | Zoladek J. et al. | 2022 | Microbiology Spectrum 10 (5) | 10.1128/spectrum.02989-22 |
| Olfactory outcomes in Zika virus-associated Guillain–Barré syndrome | Lazarini F. et al. | 2022 | European Journal of Neurology 29 (9), pp. 2823-2831 | 10.1111/ene.15444 |
| Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates | Marlin R. et al. | 2022 | Nature Communications 13 (1), pp. 5108 | 10.1038/s41467-022-32565-w |
| Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-? | Mathian A. et al. | 2022 | Annals of the Rheumatic Diseases 81 (12), pp. 1695-1703 | 10.1136/ard-2022-222549 |
| Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab | Morel A. et al. | 2022 | American Journal of Transplantation 22 (8), pp. 2099-2103 | 10.1111/ajt.17000 |
| Aspergillus detection in airways of ICU COVID-19 patients: To treat or not to treat? | Bounhiol A. ; Pasquier G. ; Novara A. ; Bougnoux M.E. ; Dannaoui E. | 2022 | Journal of Medical Mycology 32 (3), 101290 | 10.1016/j.mycmed.2022.101290 |
| The genetic and evolutionary determinants of COVID-19 susceptibility | Kerner G. ; Quintana-Murci L. | 2022 | European Journal of Human Genetics 30 (8), pp. 915-921 | 10.1038/s41431-022-01141-7 |
| Author Correction: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (Nature, (2022), 604, 7905, (330-336), 10.1038/s41586-022-04532-4) | Temmam S. et al. | 2022 | Nature 607 (7920), pp. E19 | 10.1038/s41586-022-05048-7 |
| Tunneling nanotubes provide a route for SARS-CoV-2 spreading | Pepe A. ; Pietropaoli S. ; Vos M. ; Barba-Spaeth G. ; Zurzolo C. | 2022 | Science Advances 8 (29), eabo0171 | 10.1126/sciadv.abo0171 |
| C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus | Wu Y. et al. | 2022 | Iscience 25 (7), 104537 | 10.1016/j.isci.2022.104537 |
| A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice | Brandys P. et al. | 2022 | Frontiers in Immunology 13, 912898 | 10.3389/fimmu.2022.912898 |
| Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2 | Planchais C. et al. | 2022 | Journal of Experimental Medicine 219 (7), e20220638 | 10.1084/jem.20220638 |
| A close shave: How SARS-CoV-2 induces the loss of cilia | Fonseca B.F. ; Chakrabarti L.A. | 2022 | Journal of Cell Biology 221 (7), e202206023 | 10.1083/jcb.202206023 |
| COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection | Boudhabhay I. et al. | 2022 | Nephrology Dialysis Transplantation 37 (7), pp. 1357-1365 | 10.1093/ndt/gfac016 |
| Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication | Tsuji G. et al. | 2022 | Journal of Pharmacological Sciences 149 (3), pp. 81-84 | 10.1016/j.jphs.2022.04.001 |
| Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study | Layan M. et al. | 2022 | American Journal of Epidemiology 191 (7), pp. 1224-1234 | 10.1093/aje/kwac042 |
| Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination | Garcia L. et al. | 2022 | Viruses 14 (7), 1491 | 10.3390/v14071491 |
| Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells | Aicher S.M. et al. | 2022 | Journal of Virology 96 (14) | 10.1128/jvi.00608-22 |
| Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission | Shirreff G. ; Zahar J.R. ; Cauchemez S. ; Temime L. ; Opatowski L. | 2022 | Emerging Infectious Diseases 28 (7), pp. 1345-1354 | 10.3201/eid2807.212339 |
| Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients | Attias P. et al. | 2022 | Clinical Journal of the American Society of Nephrology 17 (7), pp. 1008-1016 | 10.2215/CJN.00830122 |
| Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protection | Alexandre M. et al. | 2022 | Elife 11, e75427 | 10.7554/elife.75427 |
| Screening and vaccination against COVID-19 to minimise school closure: a modelling study | Colosi E. et al. | 2022 | Lancet Infectious Diseases 22 (7), pp. 977-989 | 10.1016/S1473-3099(22)00138-4 |
| Aedes mosquitoes in the emerging threat of urban yellow fever transmission | Gabiane G. ; Yen P.S. ; Failloux A.B. | 2022 | Reviews in Medical Virology 32 (4), e2333 | 10.1002/rmv.2333 |
| Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: Strengths, challenges, and lessons learned | Bagaria J. et al. | 2022 | Eurosurveillance 27 (26), 2100864 | 10.2807/1560-7917.ES.2022.27.26.2100864 |
| Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation | Posseme C. et al. | 2022 | Cell Reports 39 (13), 110989 | 10.1016/j.celrep.2022.110989 |
| Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France | Rybak A. et al. | 2022 | JAMA Network Open 5 (6), e2218959 | 10.1001/jamanetworkopen.2022.18959 |
| Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020 | Matczak S. et al. | 2022 | Eurosurveillance 27 (25), 2100933 | 10.2807/1560-7917.ES.2022.27.25.2100933 |
| Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens | Metcalf C.J.E. et al. | 2022 | Royal Society Open Science 9 (6), 211498 | 10.1098/rsos.211498 |
| Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant | Sokal A. et al. | 2022 | Immunity 55 (6), pp. 1096-1104.e4 | 10.1016/j.immuni.2022.04.002 |
| Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020 | Talla C. et al. | 2022 | IJID Regions 3, pp. 117-125 | 10.1016/j.ijregi.2022.02.007 |
| Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children? | Ayrolles A. et al. | 2022 | Neuropsychopharmacology Reports 42 (2), pp. 218-220 | 10.1002/npr2.12236 |
| Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with chronic inflammatory rheumatic diseases | Gros C. et al. | 2022 | Revue Du Rhumatisme Edition Francaise 89 (4), pp. 405-411 | 10.1016/j.rhum.2022.04.010 |
| Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options | Znaidia M. ; Demeret C. ; van der Werf S. ; Komarova A.V. | 2022 | Viruses 14 (6), 1247 | 10.3390/v14061247 |
| Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in A Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine | Van Elslande J. et al. | 2022 | Viruses 14 (6), 1198 | 10.3390/v14061198 |
| An early warning system for emerging SARS-CoV-2 variants | Subissi L. et al. | 2022 | Nature Medicine 28 (6), pp. 1110-1115 | 10.1038/s41591-022-01836-w |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies | Bruel T. et al. | 2022 | Nature Medicine 28 (6), pp. 1297-1302 | 10.1038/s41591-022-01792-5 |
| Public health issues and health rendezvous for migrants from conflict zones in Ukraine: A French practice guideline | Vignier N. et al. | 2022 | Infectious Diseases Now 52 (4), pp. 193-201 | 10.1016/j.idnow.2022.04.006 |
| Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis | Serris A. et al. | 2022 | Frontiers in Immunology 13, 900522 | 10.3389/fimmu.2022.900522 |
| Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 | Kissling E. et al. | 2022 | Eurosurveillance 27 (21), A1 | 10.2807/1560-7917.ES.2022.27.21.2101104 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies | Manry J. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (21), e2200413119 | 10.1073/pnas.2200413119 |
| Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study | Pandolfi F. ; Guillemot D. ; Watier L. ; Brun-Buisson C. | 2022 | BMJ Open 12 (5), e058205 | 10.1136/bmjopen-2021-058205 |
| Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody | Torres J.L. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (20), e2120976119 | 10.1073/pnas.2120976119 |
| Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2 | Auerswald H. et al. | 2022 | Frontiers in Medicine 9, 864972 | 10.3389/fmed.2022.864972 |
| A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model | Fovet C.M. et al. | 2022 | Frontiers in Immunology 13, 855230 | 10.3389/fimmu.2022.855230 |
| An ensemble model based on early predictors to forecast COVID-19 health care demand in France | Paireau J. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (18), e2103302119 | 10.1073/pnas.2103302119 |
| Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France | Decarreaux D. et al. | 2022 | Viruses 14 (5), 957 | 10.3390/v14050957 |
| Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases | Gros C. et al. | 2022 | Joint Bone Spine 89 (3), 105312 | 10.1016/j.jbspin.2021.105312 |
| Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders | Rossignol J. et al. | 2022 | Journal of Allergy and Clinical Immunology in Practice 10 (5), pp. 1356-1364.e2 | 10.1016/j.jaip.2021.12.038 |
| A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients | Benotmane I. et al. | 2022 | Kidney International 101 (5), pp. 1073-1076 | 10.1016/j.kint.2022.02.011 |
| Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers | Chouchana L. et al. | 2022 | Therapies 77 (3), pp. 371-373 | 10.1016/j.therap.2021.07.004 |
| Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish | Kraus A. et al. | 2022 | Brain Behavior and Immunity 102, pp. 341-359 | 10.1016/j.bbi.2022.03.006 |
| SARS-CoV-2 Lineage A.27: New Data from African Countries and Dynamics in the Context of the COVID-19 Pandemic | Chouikha A. et al. | 2022 | Viruses 14 (5), 1007 | 10.3390/v14051007 |
| A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors | Chen K.Y. et al. | 2022 | Antiviral Research 201, 105272 | 10.1016/j.antiviral.2022.105272 |
| A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project | Molino D. et al. | 2022 | Nature Medicine 28 (5), pp. 882-884 | 10.1038/s41591-022-01785-4 |
| Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants | Blanquart F. ; Hozé N. ; Cowling B.J. ; Débarre F. ; Cauchemez S. | 2022 | Elife 11, e75791 | 10.7554/eLife.75791 |
| Occurrence and transmission potential of asymptomatic and presymptomatic SARSCoV-2 infections: Update of a living systematic review and meta-analysis | Buitrago-Garcia D. et al. | 2022 | Plos Medicine 19 (5), e1003987 | 10.1371/journal.pmed.1003987 |
| Studying severe long COVID to understand post-infectious disorders beyond COVID-19 | Brodin P. et al. | 2022 | Nature Medicine 28 (5), pp. 879-882 | 10.1038/s41591-022-01766-7 |
| Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study | Chen Y. et al. | 2022 | Lancet Infectious Diseases 22 (5), pp. 657-667 | 10.1016/S1473-3099(22)00025-1 |
| Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic | Deghmane A.E. ; Taha M.K. | 2022 | Microorganisms 10 (5), 907 | 10.3390/microorganisms10050907 |
| First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 | Maisa A. et al. | 2022 | Infectious Diseases Now 52 (3), pp. 160-164 | 10.1016/j.idnow.2022.02.003 |
| Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic | Bara W. ; Brun-Buisson C. ; Coignard B. ; Watier L. | 2022 | Antibiotics 11 (5), 643 | 10.3390/antibiotics11050643 |
| What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda | Bonner K.E. et al. | 2022 | Plos One 17 (5 May), e0268063 | 10.1371/journal.pone.0268063 |
| Bat coronaviruses related to SARS-CoV-2 and infectious for human cells | Temmam S. et al. | 2022 | Nature 604 (7905), pp. 330-336 | 10.1038/s41586-022-04532-4 |
| COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis | Cherif I. et al. | 2022 | Diagnostics 12 (4), 971 | 10.3390/diagnostics12040971 |
| BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus | Moyon Q. et al. | 2022 | Annals of the Rheumatic Diseases 81 (4), pp. 575-583 | 10.1136/annrheumdis-2021-221097 |
| Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH | Rensen E. et al. | 2022 | Life Science Alliance 5 (4), 202101124 | 10.26508/lsa.202101124 |
| Contributions of modelling for the control of COVID-19 nosocomial transmission | Opatowski L. ; Temime L. | 2022 | Anaesthesia Critical Care and Pain Medicine 41 (2), 101054 | 10.1016/j.accpm.2022.101054 |
| Towards SARS-CoV-2 serotypes? | Simon-Loriere E. ; Schwartz O. | 2022 | Nature Reviews Microbiology 20 (4), pp. 187-188 | 10.1038/s41579-022-00708-x |
| Epidemic models: why and how to use them | Sofonea M.T. ; Cauchemez S. ; Boëlle P.Y. | 2022 | Anaesthesia Critical Care and Pain Medicine 41 (2), 101048 | 10.1016/j.accpm.2022.101048 |
| Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021 | Moirangthem S. et al. | 2022 | Euro Surveillance Bulletin Europeen Sur Les Maladies Transmissibles European Communicable Disease Bulletin 27 (17) | 10.2807/1560-7917.ES.2022.27.17.2100617 |
| Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020 | Debin M. et al. | 2022 | Euro Surveillance Bulletin Europeen Sur Les Maladies Transmissibles European Communicable Disease Bulletin 27 (17) | 10.2807/1560-7917.ES.2022.27.17.2100515 |
| Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022 | Bastard J. et al. | 2022 | Eurosurveillance 27 (13) | 10.2807/1560-7917.ES.2022.27.13.2200247 |
| The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation | Rajah M.M. ; Bernier A. ; Buchrieser J. ; Schwartz O. | 2022 | Journal of Molecular Biology 434 (6), 167280 | 10.1016/j.jmb.2021.167280 |
| Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner: Effectors of the anti-flavivirus response | Lesage S. et al. | 2022 | Journal of Molecular Biology 434 (6), 167277 | 10.1016/j.jmb.2021.167277 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia | Zhang Q. et al. | 2022 | Nature 603 (7902), pp. 587-598 | 10.1038/s41586-022-04447-0 |
| Association between growth of the SARS-CoV-2 epidemic and increased coughing rate in cold temperatures: Surveillance in Hokkaido, Japan | Inaida S. ; Paul R. | 2022 | BMJ Open 12 (3), e051534 | 10.1136/bmjopen-2021-051534 |
| Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder | Laghi V. et al. | 2022 | Frontiers in Cellular and Infection Microbiology 12, 790851 | 10.3389/fcimb.2022.790851 |
| SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance | Montagutelli X. ; van der Werf S. ; Rey F.A. ; Simon-Loriere E. | 2022 | EMBO Molecular Medicine 14 (3), e15558 | 10.15252/emmm.202115558 |
| COVID-19 vaccination, time for a second breath? | Gerke C.E. ; Pulverer B. ; Sansonetti P.J. | 2022 | EMBO Molecular Medicine 14 (3), e15810 | 10.15252/emmm.202215810 |
| Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial | Delaugerre C. et al. | 2022 | Lancet Infectious Diseases 22 (3), pp. 341-348 | 10.1016/S1473-3099(21)00673-3 |
| Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 | Saunders N. et al. | 2022 | Ebiomedicine 77, 103934 | 10.1016/j.ebiom.2022.103934 |
| COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review | Benhadid-Brahmi Y. et al. | 2022 | Journal of Medical Mycology 32 (1), 101231 | 10.1016/j.mycmed.2021.101231 |
| Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis – Authors' reply | Gangneux J.P. et al. | 2022 | Lancet Respiratory Medicine 10 (3), pp. e27 | 10.1016/S2213-2600(22)00048-0 |
| Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis? | Dellière S. et al. | 2022 | Journal of Clinical Microbiology 60 (3), e02169-21 | 10.1128/jcm.02169-21 |
| sgDI-tector: Defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs | Di Gioacchino A. et al. | 2022 | RNA 28 (3), pp. 277-289 | 10.1261/rna.078969.121 |
| Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner | Garnier Y. et al. | 2022 | British Journal of Haematology 196 (5), pp. 1159-1169 | 10.1111/bjh.18019 |
| Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review | Alderson M.R. et al. | 2022 | Journal of Infection 84 (3), pp. 289-296 | 10.1016/j.jinf.2021.11.016 |
| Assessment of surveillance predictors for suspected respiratory syncytial virus, influenza and Streptococcus pneumoniae infections in children aged <5 years in Madagascar | Razanajatovo N.H. et al. | 2022 | IJID Regions 2, pp. 82-89 | 10.1016/j.ijregi.2021.12.003 |
| COVID-19 and the Burden of Confinement on Women’s Health: A Comparison between France and the United States | Merchant J. ; Vidal C. | 2022 | International Journal of Feminist Approaches to Bioethics 15 (1), pp. 119-122 | 10.3138/ijfab-15.1.14 |
| SARS-CoV-2 Induces Cytokine Responses in Human Basophils | Bonam S.R. et al. | 2022 | Frontiers in Immunology 13, 838448 | 10.3389/fimmu.2022.838448 |
| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization | Planas D. et al. | 2022 | Nature 602 (7898), pp. 671-675 | 10.1038/s41586-021-04389-z |
| Conditionality of COVID-19 vaccine acceptance in European countries | Heyerdahl L.W. et al. | 2022 | Vaccine 40 (9), pp. 1191-1197 | 10.1016/j.vaccine.2022.01.054 |
| Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine | Gallais F. et al. | 2022 | Frontiers in Immunology 13, 790212 | 10.3389/fimmu.2022.790212 |
| Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins | Zhu Y. et al. | 2022 | Frontiers in Microbiology 13, 829094 | 10.3389/fmicb.2022.829094 |
| Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study | Diarra M. et al. | 2022 | BMJ Global Health 7 (2), e007236 | 10.1136/bmjgh-2021-007236 |
| The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions | Cooke J. et al. | 2022 | Frontiers in Neuroscience 16, 806990 | 10.3389/fnins.2022.806990 |
| Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection | Sulbaran G. et al. | 2022 | Cell Reports Medicine 3 (2), 100528 | 10.1016/j.xcrm.2022.100528 |
| Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation | Miyara M. et al. | 2022 | Frontiers in Immunology 13, 790334 | 10.3389/fimmu.2022.790334 |
| Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis | Cantaert T. ; Jouvenet N. ; Diehl S.A. | 2022 | Frontiers in Immunology 13, 835731 | 10.3389/fimmu.2022.835731 |
| Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 | Alizon S. et al. | 2022 | Eurosurveillance 27 (6), 2100406 | 10.2807/1560-7917.ES.2022.27.6.2100406 |
| Early chains of transmission of COVID-19 in France, January to March 2020 | Paireau J. et al. | 2022 | Eurosurveillance 27 (6), 2001953 | 10.2807/1560-7917.ES.2022.27.6.2001953 |
| Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma | Henriquez S. et al. | 2022 | Blood 139 (6), pp. 942-946 | 10.1182/blood.2021013714 |
| A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection | Singh M. et al. | 2022 | EMBO Reports 23 (2), e54341 | 10.15252/embr.202154341 |
| Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort | Vo H.T.M. et al. | 2022 | Frontiers in Immunology 13, 817905 | 10.3389/fimmu.2022.817905 |
| A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study | Fillâtre P. et al. | 2022 | Clinical Microbiology and Infection 28 (2), pp. 298-298.e15 | 10.1016/j.cmi.2021.09.035 |
| A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection | Andreakos E. et al. | 2022 | Nature Immunology 23 (2), pp. 159-164 | 10.1038/s41590-021-01030-z |
| Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load Than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms? | Bonnet C. et al. | 2022 | Life 12 (2), 163 | 10.3390/life12020163 |
| High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infection | Galmiche S. et al. | 2022 | Infectious Diseases Now 52 (1), pp. 52-53 | 10.1016/j.idnow.2021.11.005 |
| Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France | Grant R. et al. | 2022 | Lancet Regional Health Europe 13, 100278 | 10.1016/j.lanepe.2021.100278 |
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway | Boussier J. et al. | 2022 | Journal of Allergy and Clinical Immunology 149 (2), pp. 550-556.e2 | 10.1016/j.jaci.2021.11.004 |
| Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication | Danion F. et al. | 2022 | Open Forum Infectious Diseases 9 (2), ofab566 | 10.1093/ofid/ofab566 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study | Gangneux J.P. et al. | 2022 | Lancet Respiratory Medicine 10 (2), pp. 180-190 | 10.1016/S2213-2600(21)00442-2 |
| Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (Nature Immunology, (2022), 23, 2, (159-164), 10.1038/s41590-021-01030-z) | Andreakos E. et al. | 2022 | Nature Immunology 23 (2), pp. 341 | 10.1038/s41590-021-01096-9 |
| FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D | Scheck M.K. et al. | 2022 | Plos One 17 (2 February), e0262149 | 10.1371/journal.pone.0262149 |
| The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity | Kovacevic A. ; Eggo R.M. ; Baguelin M. ; Domenech De Cellès M. ; Opatowski L. | 2022 | Journal of Infectious Diseases 225 (2), pp. 199-207 | 10.1093/infdis/jiab459 |
| Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22 | Bosetti P. et al. | 2022 | Eurosurveillance 27 (1), 2101125 | 10.2807/1560-7917.ES.2022.27.1.2101125 |
| BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 | Samelson A.J. et al. | 2022 | Nature Cell Biology 24 (1), pp. 24-34 | 10.1038/s41556-021-00821-8 |
| Nicotinic receptors as SARS-CoV-2 spike co-receptors? | Dormoy V. et al. | 2022 | Medical Hypotheses 158, 110741 | 10.1016/j.mehy.2021.110741 |
| Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases | Tekpinar M. ; Yildirim A. | 2022 | Journal of Biomolecular Structure and Dynamics 40 (14), pp. 6243-6254 | 10.1080/07391102.2021.1880481 |
| Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein | Gransagne M. et al. | 2022 | Journal of Biological Chemistry 298 (1), 101290 | 10.1016/j.jbc.2021.101290 |
| Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study | Launay O. et al. | 2022 | Ebiomedicine 75, 103810 | 10.1016/j.ebiom.2021.103810 |
| Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines | Oliu-Barton M. et al. | 2022 | Lancet Global Health 10 (1), pp. e142-e147 | 10.1016/S2214-109X(21)00494-0 |
| Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection | Rodero M.P. et al. | 2022 | Journal of Clinical Immunology 42 (1), pp. 25-27 | 10.1007/s10875-021-01119-y |
| Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection | Maisonnasse P. et al. | 2022 | Gastro Hep Advances 1 (3), pp. 393-402 | 10.1016/j.gastha.2021.12.009 |
| Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases | Hadjadj J. et al. | 2022 | Annals of the Rheumatic Diseases 81 (5), pp. 720-728 | 10.1136/annrheumdis-2021-221508 |
| Integrating Social Sciences to Mitigate Against Covid | Paul R. ; Telle O. ; Benkimoun S. | 2022 | Economics Law and Institutions in Asia Pacific , pp. 47-71 | 10.1007/978-981-16-5727-6_3 |
| Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection (Journal of Clinical Immunology, (2022), 42, 1, (25-27), 10.1007/s10875-021-01119-y) | Rodero M.P. et al. | 2022 | Journal of Clinical Immunology 42 (1), pp. 28 | 10.1007/s10875-021-01135-y |
| Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission (Nature Medicine, (2021), 27, 11, (1854-1855), 10.1038/s41591-021-01545-w) | Kraemer M.U.G. et al. | 2022 | Nature Medicine 28 (1), pp. 213 | 10.1038/s41591-021-01670-6 |
| The COVID-19 Outbreak and Public Health Issues: An Interdisciplinary Approach | Sakuntabhai A. ; Thomann B. | 2022 | Economics Law and Institutions in Asia Pacific , pp. 341-353 | 10.1007/978-981-16-5727-6_15 |
| Rethinking the Infodemic: Social Media and Offline Action in the COVID-19 Pandemic | Heyerdahl L.W. ; Lana B. ; Giles-Vernick T. | 2022 | Economics Law and Institutions in Asia Pacific , pp. 73-82 | 10.1007/978-981-16-5727-6_4 |
| The Pasteurian contribution to the history of vaccines | Schwartz M. | 2022 | Comptes Rendus Biologies 345 (3), pp. 93-107 | 10.5802/crbiol.83 |
| Incidence and prevalence of coma in the UK and the USA | Kondziella D. et al. | 2022 | Brain Communications 4 (5), fcac188 | 10.1093/braincomms/fcac188 |
| Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells | Bernhauerová V. ; Lisowski B. ; Rezelj V.V. ; Vignuzzi M. | 2021 | Journal of Theoretical Biology 531, 110895 | 10.1016/j.jtbi.2021.110895 |
| Mapping the human genetic architecture of COVID-19 | Niemi M.E.K. et al. | 2021 | Nature 600 (7889), pp. 472-477 | 10.1038/s41586-021-03767-x |
| SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation | Rajah M.M. et al. | 2021 | EMBO Journal 40 (24), e108944 | 10.15252/embj.2021108944 |
| mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants | Sokal A. et al. | 2021 | Immunity 54 (12), pp. 2893-2907.e5 | 10.1016/j.immuni.2021.09.011 |
| Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice | Ku M.W. et al. | 2021 | EMBO Molecular Medicine 13 (12), e14459 | 10.15252/emmm.202114459 |
| Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2 | De Cellès M.D. ; Casalegno J.S. ; Lina B. ; Opatowski L. | 2021 | Peerj 9, e12566 | 10.7717/peerj.12566 |
| Lockdown impact on age-specific contact patterns and behaviours, France, April 2020 | Bosetti P. et al. | 2021 | Eurosurveillance 26 (48), 2001636 | 10.2807/1560-7917.ES.2021.26.48.2001636 |
| Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa | Fares W. et al. | 2021 | BMC Genomics 22 (1), 540 | 10.1186/s12864-021-07870-1 |
| A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters | Frantz P.N. et al. | 2021 | Nature Communications 12 (1), 6277 | 10.1038/s41467-021-26506-2 |
| Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2) | Weiss A. et al. | 2021 | Plos One 16 (12 December), e0260958 | 10.1371/journal.pone.0260958 |
| Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients | Crescenzo-Chaigne B. et al. | 2021 | Journal of Clinical Virology Plus 1 (4), 100041 | 10.1016/j.jcvp.2021.100041 |
| SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance | Robinot R. et al. | 2021 | Nature Communications 12 (1), 4354 | 10.1038/s41467-021-24521-x |
| Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential | Meyer B. et al. | 2021 | Nature Communications 12 (1), 5553 | 10.1038/s41467-021-25796-w |
| A novel SARS-CoV-2 related coronavirus in bats from Cambodia | Delaune D. et al. | 2021 | Nature Communications 12 (1), 6563 | 10.1038/s41467-021-26809-4 |
| Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis | Goubet A.G. et al. | 2021 | Cell Death and Differentiation 28 (12), pp. 3297-3315 | 10.1038/s41418-021-00817-9 |
| Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers | Marot S. et al. | 2021 | Nature Communications 12 (1), 844 | 10.1038/s41467-021-21111-9 |
| Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance | Le Vu S. et al. | 2021 | Nature Communications 12 (1), 3025 | 10.1038/s41467-021-23233-6 |
| Clash of the titans: interferons and SARS-CoV-2 | Jouvenet N. ; Goujon C. ; Banerjee A. | 2021 | Trends in Immunology 42 (12), pp. 1069-1072 | 10.1016/j.it.2021.10.009 |
| Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques | Marlin R. et al. | 2021 | Nature Communications 12 (1), 5215 | 10.1038/s41467-021-25382-0 |
| Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana | Andronico A. et al. | 2021 | Nature Communications 12 (1), 1634 | 10.1038/s41467-021-21944-4 |
| Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions | Dudas G. et al. | 2021 | Nature Communications 12 (1), 5769 | 10.1038/s41467-021-26055-8 |
| Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave | Landier J. et al. | 2021 | Scientific Reports 11 (1), 12756 | 10.1038/s41598-021-91798-9 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models | Maisonnasse P. et al. | 2021 | Nature Communications 12 (1), 6097 | 10.1038/s41467-021-26354-0 |
| Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry | Aeschlimann F.A. et al. | 2021 | Journal of Cardiovascular Magnetic Resonance 23 (1), 140 | 10.1186/s12968-021-00841-1 |
| Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care | LeGoff J. et al. | 2021 | Scientific Reports 11 (1), 21126 | 10.1038/s41598-021-00560-8 |
| Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges | Terrier O. et al. | 2021 | Plos Pathogens 17 (12), e1010106 | 10.1371/journal.ppat.1010106 |
| Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department | NguyenVan J.C. et al. | 2021 | Journal of Clinical Virology 145, 105021 | 10.1016/j.jcv.2021.105021 |
| Deciphering the state of immune silence in fatal COVID-19 patients | Bost P. et al. | 2021 | Nature Communications 12 (1), 1428 | 10.1038/s41467-021-21702-6 |
| SARS-CoV-2 transmission across age groups in France and implications for control | Tran Kiem C. et al. | 2021 | Nature Communications 12 (1), 6895 | 10.1038/s41467-021-27163-1 |
| Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them | de Laval F. et al. | 2021 | BMC Infectious Diseases 21 (1), 457 | 10.1186/s12879-021-06166-9 |
| Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak* | Frumholtz L. et al. | 2021 | British Journal of Dermatology 185 (6), pp. 1176-1185 | 10.1111/bjd.20707 |
| A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries | Sera F. et al. | 2021 | Nature Communications 12 (1), 5968 | 10.1038/s41467-021-25914-8 |
| Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients | Courties A. et al. | 2021 | Scientific Reports 11 (1), 11886 | 10.1038/s41598-021-91417-7 |
| Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic | Gagneux-Brunon A. et al. | 2021 | Trials 22 (1), 373 | 10.1186/s13063-021-05329-y |
| Guidelines of the French Society of Otorhinolaryngology (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemic | Bertholon P. et al. | 2021 | European Annals of Otorhinolaryngology Head and Neck Diseases 138 (6), pp. 459-465 | 10.1016/j.anorl.2020.11.011 |
| Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic | Cassius C. et al. | 2021 | British Journal of Dermatology 185 (6), pp. 1242-1244 | 10.1111/bjd.20647 |
| Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSV | Delestrain C. et al. | 2021 | Pediatric Pulmonology 56 (12), pp. 3669-3673 | 10.1002/ppul.25644 |
| Aspergillus test profiles and mortality in critically ill covid-19 patients | Ergün M. et al. | 2021 | Journal of Clinical Microbiology 59 (12), e01229-21 | 10.1128/JCM.01229-21 |
| Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers (Nature Communications, (2021), 12, 1, (844), 10.1038/s41467-021-21111-9) | Marot S. et al. | 2021 | Nature Communications 12 (1), 2824 | 10.1038/s41467-021-23128-6 |
| Platelet activation in critically ill COVID-19 patients | Yatim N. et al. | 2021 | Annals of Intensive Care 11 (1), 113 | 10.1186/s13613-021-00899-1 |
| The Impact of the Online COVID-19 Infodemic on French Red Cross Actors' Field Engagement and Protective Behaviors: Mixed Methods Study | Heyerdahl L.W. ; Lana B. ; Giles-Vernick T. | 2021 | Jmir Infodemiology 1 (1), e27472 | 10.2196/27472 |
| Using secondary cases to characterize the severity of an emerging or re-emerging infection | Tsang T.K. ; Wang C. ; Yang B. ; Cauchemez S. ; Cowling B.J. | 2021 | Nature Communications 12 (1), 6372 | 10.1038/s41467-021-26709-7 |
| An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal route | Majlessi L. ; Charneau P. | 2021 | Medecine Sciences 37 (12), pp. 1172-1175 | 10.1051/medsci/2021173 |
| Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic | Di Domenico L. et al. | 2021 | Communications Medicine 1 (1), 57 | 10.1038/s43856-021-00057-5 |
| Guidelines of the French Society of Otorhinolaryngology and Head and Neck Surgery (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemic | Bertholon P. et al. | 2021 | Annales Francaises D Oto Rhino Laryngologie Et De Pathologie Cervico Faciale 138 (6), pp. 462-468 | 10.1016/j.aforl.2020.10.002 |
| Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient | Cunha M.d.P. et al. | 2021 | Frontiers in Medicine 8, 760170 | 10.3389/fmed.2021.760170 |
| XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants | Vanhove B. et al. | 2021 | Frontiers in Immunology 12, 761250 | 10.3389/fimmu.2021.761250 |
| Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection | Smith N. et al. | 2021 | Nature Immunology 22 (11), pp. 1428-1439 | 10.1038/s41590-021-01028-7 |
| Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value | Veyer D. et al. | 2021 | Clinical Infectious Diseases 73 (9), pp. E2890-E2897 | 10.1093/cid/ciaa1196 |
| Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study | Kernéis S. et al. | 2021 | European Journal of Clinical Microbiology and Infectious Diseases 40 (11), pp. 2379-2388 | 10.1007/s10096-021-04327-x |
| Seroprevalence of anti-sars-cov-2 igg at the first epidemic peak in french guiana, july 2020 | Flamand C. et al. | 2021 | Plos Neglected Tropical Diseases 15 (11), e0009945 | 10.1371/journal.pntd.0009945 |
| Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study | Monel B. et al. | 2021 | Ebiomedicine 73, 103637 | 10.1016/j.ebiom.2021.103637 |
| Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients | Sacconi A. et al. | 2021 | Cell Death and Disease 12 (11), 1019 | 10.1038/s41419-021-04299-y |
| Monitoring key epidemiological parameters of SARS-CoV-2 transmission | Kraemer M.U.G. et al. | 2021 | Nature Medicine 27 (11), pp. 1854-1855 | 10.1038/s41591-021-01545-w |
| Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France | Lefèvre B. et al. | 2021 | Lancet Healthy Longevity 2 (11), pp. e685-e687 | 10.1016/S2666-7568(21)00230-0 |
| MALVIRUS: an integrated application for viral variant analysis | Ciccolella S. et al. | 2021 | BMC Bioinformatics 22, 625 | 10.1186/s12859-022-04668-0 |
| Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2 | Rivière F. et al. | 2021 | Respiratory Medicine and Research 80, 100862 | 10.1016/j.resmer.2021.100862 |
| Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2 | Frédéric R. et al. | 2021 | Respiratory Medicine and Research 80, pp. 100862 | 10.1016/j.resmer.2021.100862 |
| Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia | Ghanem M. et al. | 2021 | American Journal of Physiology Lung Cellular and Molecular Physiology 321 (5), pp. L847-L858 | 10.1152/ajplung.00545.2020 |
| Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time since Infection | Pelleau S. et al. | 2021 | Journal of Infectious Diseases 224 (9), pp. 1489-1499 | 10.1093/infdis/jiab375 |
| Pdz-containing proteins targeted by the ace2 receptor | Caillet-Saguy C. ; Wolff N. | 2021 | Viruses 13 (11), 2281 | 10.3390/v13112281 |
| Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials | Dautzenberg B. ; Levi A. ; Adler M. ; Gaillard R. | 2021 | Respiratory Medicine and Research 80, 100844 | 10.1016/j.resmer.2021.100844 |
| Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France | Fourgeaud J. et al. | 2021 | European Journal of Clinical Microbiology and Infectious Diseases 40 (11), pp. 2389-2395 | 10.1007/s10096-021-04323-1 |
| Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality | Gendron N. et al. | 2021 | Arthritis and Rheumatology 73 (11), pp. 1976-1985 | 10.1002/art.41777 |
| “We Tried to Borrow Money, but No One Helped.” Assessing the Three-Delay Model Factors Affecting the Healthcare Service Delivery among Dengue Patients during COVID-19 Surge in a Public Tertiary Hospital: A Convergent Parallel Mixed Methods Study | Ligsay A.D. et al. | 2021 | International Journal of Environmental Research and Public Health 18 (22), 11851 | 10.3390/ijerph182211851 |
| Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System | Guenver C. et al. | 2021 | Frontiers in Pediatrics 9, 745364 | 10.3389/fped.2021.745364 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa | Wilkinson E. et al. | 2021 | Science 374 (6566), pp. 423-431 | 10.1126/science.abj4336 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines | Walls A.C. et al. | 2021 | Cell 184 (21), pp. 5432-5447.e16 | 10.1016/j.cell.2021.09.015 |
| Quantifying healthcare and welfare sector workers' preferences around COVID-19 vaccination: A cross-sectional, single-profile discrete-choice experiment in France | DÍaz Luévano C. et al. | 2021 | BMJ Open 11 (10), e055148 | 10.1136/bmjopen-2021-055148 |
| COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms | Ostaszewski M. et al. | 2021 | Molecular Systems Biology 17 (10), e10387 | 10.15252/msb.202110387 |
| COVID-19-related travel restrictions temporarily reduced the demand for rabies post-exposure prophylaxis in France | Parize P. et al. | 2021 | Journal of Travel Medicine 28 (7), taab127 | 10.1093/jtm/taab127 |
| New insights into human immunity from ancient genomics | Kerner G. ; Patin E. ; Quintana-Murci L. | 2021 | Current Opinion in Immunology 72, pp. 116-125 | 10.1016/j.coi.2021.04.006 |
| Covid-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: A retrospective multicenter observational cohort during the first french pandemic wave | Bretagne S. et al. | 2021 | Microbiology Spectrum 9 (2), e01138-21 | 10.1128/Spectrum.01138-21 |
| Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) | Thai-Van H. et al. | 2021 | European Annals of Otorhinolaryngology Head and Neck Diseases 138 (5), pp. 363-375 | 10.1016/j.anorl.2020.10.007 |
| Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response | Roßmann L. et al. | 2021 | Proceedings of the National Academy of Sciences of the United States of America 118 (39), e2103651118 | 10.1073/PNAS.2103651118 |
| Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019 | Betton M. et al. | 2021 | Clinical Infectious Diseases 73 (6), pp. E1337-E1344 | 10.1093/cid/ciab308 |
| Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 | Grzelak L. et al. | 2021 | Journal of Infectious Diseases 224 (6), pp. 983-988 | 10.1093/infdis/jiab127 |
| Demographic and Clinical Characteristics Associated With Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in Gabon | Iroungou B.A. et al. | 2021 | JAMA Network Open 4 (9), pp. E2124190 | 10.1001/jamanetworkopen.2021.24190 |
| A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis | de Cevins C. et al. | 2021 | Med 2 (9), pp. 1072-1092.e7 | 10.1016/j.medj.2021.08.002 |
| An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates | Zabaleta N. et al. | 2021 | Cell Host and Microbe 29 (9), pp. 1437-1453.e8 | 10.1016/j.chom.2021.08.002 |
| Broad sarbecovirus neutralization by a human monoclonal antibody | Tortorici M.A. et al. | 2021 | Nature 597 (7874), pp. 103-108 | 10.1038/s41586-021-03817-4 |
| Host PDZ-containing proteins targeted by SARS-CoV-2 | Caillet-Saguy C. et al. | 2021 | FEBS Journal 288 (17), pp. 5148-5162 | 10.1111/febs.15881 |
| Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection | Gallais F. et al. | 2021 | Ebiomedicine 71, 103561 | 10.1016/j.ebiom.2021.103561 |
| Characteristics Associated with Olfactory and Taste Disorders in COVID-19 | Galmiche S. et al. | 2021 | Neuroepidemiology 55 (5), pp. 381-386 | 10.1159/000517066 |
| Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France | Charmet T. et al. | 2021 | Lancet Regional Health Europe 8, 100171 | 10.1016/j.lanepe.2021.100171 |
| ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads | Marchio A. et al. | 2021 | Archives of Virology 166 (9), pp. 2529-2540 | 10.1007/s00705-021-05149-0 |
| ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2 | Van Kerkhove M.D. et al. | 2021 | Influenza and Other Respiratory Viruses 15 (5), pp. 561-568 | 10.1111/irv.12870 |
| SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution | Zahradník J. et al. | 2021 | Nature Microbiology 6 (9), pp. 1188-1198 | 10.1038/s41564-021-00954-4 |
| A review of significance of Aspergillus detection in airways of ICU COVID-19 patients | Pasquier G. et al. | 2021 | Mycoses 64 (9), pp. 980-988 | 10.1111/myc.13341 |
| A bioluminescent 3clpro activity assay to monitor sars-cov-2 replication and identify inhibitors | Mathieu C. et al. | 2021 | Viruses 13 (9), 1814 | 10.3390/v13091814 |
| Managing COVID-19 importation risks in a heterogeneous world | Cauchemez S. ; Kiem C.T. | 2021 | Lancet Public Health 6 (9), pp. e626-e627 | 10.1016/S2468-2667(21)00188-2 |
| Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway | Guedj E. et al. | 2021 | Clinical Microbiology and Infection 27 (9), pp. 1196-1198 | 10.1016/j.cmi.2021.05.015 |
| Twelfth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer | Charifou E. ; Traustadottir G.A. ; Bentires-Alj M. ; Howard B. ; Van Keymeulen A. | 2021 | Journal of Mammary Gland Biology and Neoplasia 26 (3), pp. 221-226 | 10.1007/s10911-021-09498-z |
| A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1 | Parellada M. et al. | 2021 | Frontiers in Psychiatry 12, 701729 | 10.3389/fpsyt.2021.701729 |
| Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 | Drayman N. et al. | 2021 | Science 373 (6557), pp. 931-936 | 10.1126/science.abg5827 |
| Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence | Kraemer M.U.G. et al. | 2021 | Science 373 (6557), pp. 889-895 | 10.1126/science.abj0113 |
| X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 | Asano T. et al. | 2021 | Science Immunology 6 (62), eabl4348 | 10.1126/sciimmunol.abl4348 |
| Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Bastard P. et al. | 2021 | Science Immunology 6 (62), eabl4340 | 10.1126/sciimmunol.abl4340 |
| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Planas D. et al. | 2021 | Nature 596 (7871), pp. 276-280 | 10.1038/s41586-021-03777-9 |
| Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin | de Melo G.D. et al. | 2021 | EMBO Molecular Medicine 13 (8), e14122 | 10.15252/emmm.202114122 |
| Covid-19 research: Lessons from non-human primate models | Albrecht L. et al. | 2021 | Vaccines 9 (8), 886 | 10.3390/vaccines9080886 |
| Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) from a BNT162b2-Vaccinated Individual | Kerneís S. et al. | 2021 | Open Forum Infectious Diseases 8 (8), ofab369 | 10.1093/ofid/ofab369 |
| Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France | Woudenberg T. et al. | 2021 | Ebiomedicine 70, 103495 | 10.1016/j.ebiom.2021.103495 |
| Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain | Billon-Denis E. et al. | 2021 | Infection 49 (4), pp. 781-783 | 10.1007/s15010-020-01556-8 |
| The Nexus between Telomere Length and Lymphocyte Count in Seniors Hospitalized with COVID-19 | Benetos A. et al. | 2021 | Journals of Gerontology Series A Biological Sciences and Medical Sciences 76 (8), pp. E97-E101 | 10.1093/gerona/glab026 |
| Low seroprevalence of COVID-19 in Lao PDR, late 2020 | Virachith S. et al. | 2021 | Lancet Regional Health Western Pacific 13, 100197 | 10.1016/j.lanwpc.2021.100197 |
| Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis | Verweij P.E. et al. | 2021 | Intensive Care Medicine 47 (8), pp. 819-834 | 10.1007/s00134-021-06449-4 |
| Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? | Cohen R. et al. | 2021 | Infectious Diseases Now 51 (5), pp. 418-423 | 10.1016/j.idnow.2021.05.004 |
| Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study | Galmiche S. et al. | 2021 | Lancet Regional Health Europe 7, 100148 | 10.1016/j.lanepe.2021.100148 |
| Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection | Yatim N. et al. | 2021 | Science Advances 7 (34), eabg4081 | 10.1126/sciadv.abg4081 |
| What chikungunya teaches us about COVID-19 | Simon F. ; Watson H. ; Meynard J.B. ; de Santi V.P. ; Tournier J.N. | 2021 | Lancet Infectious Diseases 21 (8), pp. 1070-1071 | 10.1016/S1473-3099(21)00272-3 |
| A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures | Tran Kiem C. et al. | 2021 | Eclinicalmedicine 38, 101001 | 10.1016/j.eclinm.2021.101001 |
| Mitigating COVID-19 outbreaks in workplaces and schools by hybrid telecommuting | Mauras S. et al. | 2021 | Plos Computational Biology 17 (8), e1009264 | 10.1371/journal.pcbi.1009264 |
| Education and mental health: good reasons to vaccinate children | Cauchemez S. et al. | 2021 | Lancet 398 (10298), pp. 387 | 10.1016/S0140-6736(21)01453-7 |
| Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 | Tummino T.A. et al. | 2021 | Science 373 (6554), 6554 | 10.1126/science.abi4708 |
| SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction | Lavigne M. et al. | 2021 | Nucleic Acids Research 49 (13), pp. 7695-7712 | 10.1093/nar/gkab571 |
| How did institut pasteur’s ngs core facility, biomics, manage the coronavirus disease 2019 crisis? | Najjar I. et al. | 2021 | Journal of Biomolecular Techniques 32 (2), pp. 50-56 | 10.7171/jbt.21-3202-004 |
| Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 | Kissling E. et al. | 2021 | Euro Surveillance Bulletin Europeen Sur Les Maladies Transmissibles European Communicable Disease Bulletin 26 (29) | 10.2807/1560-7917.ES.2021.26.29.2100670 |
| Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocol | Pouquet M. et al. | 2021 | Pathogens 10 (7), 911 | 10.3390/pathogens10070911 |
| Interoperable medical data: The missing link for understanding COVID-19 | Bauer D.C. et al. | 2021 | Transboundary and Emerging Diseases 68 (4), pp. 1753-1760 | 10.1111/tbed.13892 |
| SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse | Konings F. et al. | 2021 | Nature Microbiology 6 (7), pp. 821-823 | 10.1038/s41564-021-00932-w |
| A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic | Cazelles B. et al. | 2021 | Plos Computational Biology 17 (7), e1009211 | 10.1371/journal.pcbi.1009211 |
| Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: A modelling study, France, May to September 2021 | Kiem C.T. et al. | 2021 | Eurosurveillance 5 (13) | 10.2807/1560-7917.ES.2021.26.26.2100533 |
| Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020 | Kissling E. et al. | 2021 | Influenza and Other Respiratory Viruses 15 (4), pp. 429-438 | 10.1111/irv.12839 |
| Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021 | Tran Kiem C. et al. | 2021 | Euro Surveillance Bulletin Europeen Sur Les Maladies Transmissibles European Communicable Disease Bulletin 26 (26) | 10.2807/1560-7917.ES.2021.26.26.2100533 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 world | Toor J. et al. | 2021 | Elife 10, e67635 | 10.7554/eLife.67635 |
| Host-pathogen adhesion as the basis of innovative diagnostics for emerging pathogens | van Belkum A. et al. | 2021 | Diagnostics 11 (7), 1259 | 10.3390/diagnostics11071259 |
| A review and agenda for integrated disease models including social and behavioural factors | Bedson J. et al. | 2021 | Nature Human Behaviour 5 (7), pp. 834-846 | 10.1038/s41562-021-01136-2 |
| Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemic | Gouel-Cheron A. et al. | 2021 | British Journal of Anaesthesia 127 (1), pp. e35-e37 | 10.1016/j.bja.2021.04.001 |
| COVID-Align: Accurate online alignment of hCoV-19 genomes using a profile HMM | Lemoine F. ; Blassel L. ; Voznica J. ; Gascuel O. | 2021 | Bioinformatics 37 (12), pp. 1761-1762 | 10.1093/bioinformatics/btaa871 |
| Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry | Firpo M.R. et al. | 2021 | ACS Infectious Diseases 7 (6), pp. 1423-1432 | 10.1021/acsinfecdis.0c00491 |
| COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters | de Melo G.D. et al. | 2021 | Science Translational Medicine 13 (596), eabf8396 | 10.1126/scitranslmed.abf8396 |
| High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households | Fritz M. et al. | 2021 | One Health 11, 100192 | 10.1016/j.onehlt.2020.100192 |
| High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 | Vanhove B. et al. | 2021 | European Journal of Immunology 51 (6), pp. 1412-1422 | 10.1002/eji.202049072 |
| The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2 | Di Gioacchino A. et al. | 2021 | Molecular Biology and Evolution 38 (6), pp. 2428-2445 | 10.1093/molbev/msab036 |
| Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population | Lapidus N. et al. | 2021 | Infectious Diseases Now 51 (4), pp. 380-382 | 10.1016/j.idnow.2020.12.007 |
| Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study | Hozé N. et al. | 2021 | Lancet Public Health 6 (6), pp. e408-e415 | 10.1016/S2468-2667(21)00064-5 |
| Lockdown as a last resort option in case of COVID-19 epidemic rebound: A modelling study | Kiem C.T. et al. | 2021 | Eurosurveillance 26 (22) | 10.2807/1560-7917.ES.2021.26.22.2001536 |
| Heat inactivation of the severe acute respiratory syndrome coronavirus 2 | Batéjat C. ; Grassin Q. ; Manuguerra J.C. ; Leclercq I. | 2021 | Journal of Biosafety and Biosecurity 3 (1), pp. 1-3 | 10.1016/j.jobb.2020.12.001 |
| Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis | Lefrancq N. et al. | 2021 | Lancet Regional Health Europe 5, 100087 | 10.1016/j.lanepe.2021.100087 |
| COVID-19 containment measures and incidence of invasive bacterial disease | Smith D.R.M. ; Opatowski L. | 2021 | Lancet Digital Health 3 (6), pp. e331-e332 | 10.1016/S2589-7500(21)00085-6 |
| Fungal infections should be part of the core outcome set for COVID-19 | Verweij P.E. ; Alanio A. | 2021 | Lancet Infectious Diseases 21 (6), pp. e145 | 10.1016/S1473-3099(20)30591-0 |
| Ousted health care workers because of COVID-19 infection: Back to work is not an easy move | GOUEL-CHERON A. ; DEN BERGH M.V. ; CRESTANI B. ; MONTRAVERS P. | 2021 | Anaesthesia Critical Care and Pain Medicine 40 (3), 100752 | 10.1016/j.accpm.2020.09.008 |
| Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality | Bernigaud C. et al. | 2021 | British Journal of Dermatology 184 (6), pp. 1207-1209 | 10.1111/bjd.19821 |
| Structural basis for broad coronavirus neutralization | Sauer M.M. et al. | 2021 | Nature Structural and Molecular Biology 28 (6), pp. 478-486 | 10.1038/s41594-021-00596-4 |
| Ivermectin as a potential treatment for covid-19? | Chosidow O. et al. | 2021 | Plos Neglected Tropical Diseases 15 (6), e0009446 | 10.1371/journal.pntd.0009446 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data | Brueggemann A.B. et al. | 2021 | Lancet Digital Health 3 (6), pp. e360-e370 | 10.1016/S2589-7500(21)00077-7 |
| Diversity in immunogenomics: the value and the challenge | Peng K. et al. | 2021 | Nature Methods 18 (6), pp. 588-591 | 10.1038/s41592-021-01169-5 |
| Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies | Dufloo J. et al. | 2021 | Cell Reports Medicine 2 (5), 100275 | 10.1016/j.xcrm.2021.100275 |
| Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives | Le Hingrat Q. et al. | 2021 | Clinical Microbiology and Infection 27 (5), pp. 789-789.e5 | 10.1016/j.cmi.2020.11.025 |
| Are posterior oropharyngeal saliva specimens an acceptable alternative to nasopharyngeal sampling for the monitoring of sars-cov-2 in primary-care settings? | Masse S. et al. | 2021 | Viruses 13 (5), 761 | 10.3390/v13050761 |
| Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies | Planas D. et al. | 2021 | Nature Medicine 27 (5), pp. 917-924 | 10.1038/s41591-021-01318-5 |
| Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic | Berteloot L. et al. | 2021 | American Journal of Transplantation 21 (5), pp. 1937-1943 | 10.1111/ajt.16464 |
| Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort | Dellière S. et al. | 2021 | Clinical Microbiology and Infection 27 (5), pp. 790-790.e5 | 10.1016/j.cmi.2020.12.005 |
| High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort | Tubiana S. et al. | 2021 | Journal of Infection 82 (5), pp. 186-230 | 10.1016/j.jinf.2021.01.026 |
| Complement inhibition in severe COVID-19 – Blocking C5a seems to be key: Author's reply | Annane D. ; Grimaldi-Bensouda L. ; Fremeaux-Bacchic V. | 2021 | Eclinicalmedicine 35, 100866 | 10.1016/j.eclinm.2021.100866 |
| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 | McCallum M. et al. | 2021 | Cell 184 (9), pp. 2332-2347.e16 | 10.1016/j.cell.2021.03.028 |
| Virology | Saleh M.C. ; Rey F.A. | 2021 | Virology , pp. 1-368 | 10.1002/9781119818526 |
| SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? | Sancho-Shimizu V. et al. | 2021 | Journal of Experimental Medicine 218 (6), e20210446 | 10.1084/jem.20210446 |
| Stealth Fluorescence Labeling for Live Microscopy Imaging of mRNA Delivery | Baladi T. et al. | 2021 | Journal of the American Chemical Society 143 (14), pp. 5413-5424 | 10.1021/jacs.1c00014 |
| Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 | Sermet-Gaudelus I. et al. | 2021 | Eurosurveillance 26 (13), 2001782 | 10.2807/1560-7917.ES.2021.26.13.2001782 |
| Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli | Madru C. et al. | 2021 | Plos One 16 (4 April), e0250610 | 10.1371/journal.pone.0250610 |
| Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France | Toubiana J. et al. | 2021 | Journal of Clinical Immunology 41 (3), pp. 526-535 | 10.1007/s10875-020-00941-0 |
| Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia | de Prost N. et al. | 2021 | Journal of Clinical Immunology 41 (3), pp. 536-544 | 10.1007/s10875-021-00994-9 |
| Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study | Roederer T. et al. | 2021 | Lancet Public Health 6 (4), pp. e202-e209 | 10.1016/S2468-2667(21)00001-3 |
| Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021 | Calba C. et al. | 2021 | Eurosurveillance 26 (13) | 10.2807/1560-7917.ES.2021.26.13.2100333 |
| Virus eradication and synthetic biology: Changes with sars-cov-2? | Tournier J.N. ; Kononchik J. | 2021 | Viruses 13 (4), 569 | 10.3390/v13040569 |
| Outcome of asymptomatic patients with positive SARS-CoV-2 viral RNA reverse transcriptase-PCR undergoing surgery: A matched cohort study | Verliere A. et al. | 2021 | European Journal of Anaesthesiology 38 (4), pp. 442-444 | 10.1097/EJA.0000000000001426 |
| SARS-CoV-2 population-based seroprevalence studies in Europe: A scoping review | Grant R. et al. | 2021 | BMJ Open 11 (4), e045425 | 10.1136/bmjopen-2020-045425 |
| The presence of Pneumocystis jirovecii in critically ill patients with COVID-19 | Alanio A. ; Dellière S. ; Voicu S. ; Bretagne S. ; Mégarbane B. | 2021 | Journal of Infection 82 (4), pp. 84-123 | 10.1016/j.jinf.2020.10.034 |
| Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19 | Issa H. et al. | 2021 | Frontiers in Medicine 8, 620990 | 10.3389/fmed.2021.620990 |
| SARS-CoV-2 viral dynamics in non-human primates | Gonçalves A. et al. | 2021 | Plos Computational Biology 17 (3), e1008785 | 10.1371/JOURNAL.PCBI.1008785 |
| Genomic characterization and phylogenetic analysis of the first SARS-CoV-2 variants introduced in Lebanon | Feghali R. et al. | 2021 | Peerj 9, 11015 | 10.7717/peerj.11015 |
| SARS-CoV-2 variants and ending the COVID-19 pandemic | Fontanet A. et al. | 2021 | Lancet 397 (10278), pp. 952-954 | 10.1016/S0140-6736(21)00370-6 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection | Brouwer P.J.M. et al. | 2021 | Cell 184 (5), pp. 1188-1200.e19 | 10.1016/j.cell.2021.01.035 |
| Maturation and persistence of the anti-SARS-CoV-2 memory B cell response | Sokal A. et al. | 2021 | Cell 184 (5), pp. 1201-1213.e14 | 10.1016/j.cell.2021.01.050 |
| Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021 | Gaymard A. et al. | 2021 | Eurosurveillance 26 (9) | 10.2807/1560-7917.ES.2021.26.9.2100133 |
| Association of Intravenous Immunoglobulins plus Methylprednisolone vs Immunoglobulins Alone with Course of Fever in Multisystem Inflammatory Syndrome in Children | Ouldali N. et al. | 2021 | JAMA Journal of the American Medical Association 325 (9), pp. 855-864 | 10.1001/jama.2021.0694 |
| Parallel trends in the transmission of SARS-CoV-2 and retail/recreation and public transport mobility during non-lockdown periods | Cazelles B. ; Comiskey C. ; Nguyen-Van-Yen B. ; Champagne C. ; Roche B. | 2021 | International Journal of Infectious Diseases 104, pp. 693-695 | 10.1016/j.ijid.2021.01.067 |
| Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine | Plaze M. et al. | 2021 | International Journal of Antimicrobial Agents 57 (3), 106274 | 10.1016/j.ijantimicag.2020.106274 |
| Factors associated with severe SARS-CoV-2 infection | Ouldali N. et al. | 2021 | Pediatrics 147 (3), e2020023432 | 10.1542/PEDS.2020-023432 |
| Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 among Healthcare Workers of a French University Hospital in Paris, France | Contejean A. et al. | 2021 | Open Forum Infectious Diseases 8 (3) | 10.1093/ofid/ofab054 |
| Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 | Fertitta L. et al. | 2021 | Journal of the European Academy of Dermatology and Venereology 35 (3), pp. e164-e167 | 10.1111/jdv.16972 |
| Is This a Healthy Scientific Controversy or the "savior" Syndrome at Play? COVID-19 and the Hydroxychloroquine Example | Boneca I.G. | 2021 | Microbial Drug Resistance 27 (3), pp. 279-280 | 10.1089/mdr.2021.29001.igb |
| COVID-19 vaccination for cancer patients: Medical and ethical need | Spano J.P. ; Barre-Sinoussi F. ; Kieny M.P. ; Marcelin A.G. ; Blay J.Y. | 2021 | Bulletin Du Cancer 108 (3), pp. 225-227 | 10.1016/j.bulcan.2021.02.001 |
| Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case report | Ghelfenstein-Ferreira T. et al. | 2021 | Medical Mycology Case Reports 31, pp. 15-18 | 10.1016/j.mmcr.2020.06.006 |
| A self-assessment web-based app to assess trends of the COVID-19 pandemic in France: Observational study | Denis F. et al. | 2021 | Journal of Medical Internet Research 23 (3), e26182 | 10.2196/26182 |
| COVID-19 Job Exposure Matrix From the Mat-O-Covid Design to Its Execution | Fadel M. ; Salomon J. ; Descatha A. | 2021 | Journal of Occupational and Environmental Medicine 63 (3), pp. E168 | 10.1097/JOM.0000000000002148 |
| Biostatistics to better detect fishy findings | Tarantola A. ; Gautier L. | 2021 | Lancet Infectious Diseases 21 (3), pp. 316-317 | 10.1016/S1473-3099(20)30557-0 |
| To quarantine, or not to quarantine: A theoretical framework for disease control via contact tracing | Lunz D. ; Batt G. ; Ruess J. | 2021 | Epidemics 34, 100428 | 10.1016/j.epidem.2020.100428 |
| Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021 | Adlhoch C. et al. | 2021 | Eurosurveillance 26 (11), pp. 1-8 | 10.2807/1560-7917.ES.2021.26.11.2100221 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A | White K.M. et al. | 2021 | Science 371 (6532), pp. 926-931 | 10.1126/science.abf4058 |
| Covid-19: Keeping schools as safe as possible | Fontanet A. ; Grant R. ; Greve-Isdahl M. ; Sridhar D. | 2021 | BMJ 372, n524 | 10.1136/bmj.n524 |
| Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models | Ku M.W. et al. | 2021 | Cell Host and Microbe 29 (2), pp. 236-249.e6 | 10.1016/j.chom.2020.12.010 |
| The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome | Brett Finlay B. et al. | 2021 | Proceedings of the National Academy of Sciences of the United States of America 118 (6), e2010217118 | 10.1073/pnas.2010217118 |
| Age-specific mortality and immunity patterns of SARS-CoV-2 | O’Driscoll M. et al. | 2021 | Nature 590 (7844), pp. 140-145 | 10.1038/s41586-020-2918-0 |
| Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient | Szwebel T.A. et al. | 2021 | Stem Cell Reviews and Reports 17 (1), pp. 296-299 | 10.1007/s12015-020-10107-5 |
| Institut Pasteur International Network's efforts to guide control measures against the coronavirus disease 2019 (COVID-19) epidemic among healthcare workers in Africa | Randremanana R. et al. | 2021 | International Journal of Infectious Diseases 103, pp. 525-526 | 10.1016/j.ijid.2020.12.032 |
| Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study | Rosado J. et al. | 2021 | Lancet Microbe 2 (2), pp. e60-e69 | 10.1016/S2666-5247(20)30197-X |
| When Therapeutic IgA Antibodies Might Come of Age | Sterlin D. ; Gorochov G. | 2021 | Pharmacology 106 (1-2), pp. 9-19 | 10.1159/000510251 |
| Persistent bilateral Tapia syndrome following critical COVID-19 | Yatim N. ; Bonnet N. ; Wing Tin S.N. ; Cohen Y. ; Degos B. | 2021 | Clinical Neurophysiology 132 (2), pp. 505-506 | 10.1016/j.clinph.2020.12.007 |
| Evaluating the motivation of Red Cross Health volunteers in the COVID-19 pandemic: A mixed-methods study protocol | Heyerdahl L.W. et al. | 2021 | BMJ Open 11 (1), e042579 | 10.1136/bmjopen-2020-042579 |
| IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Sterlin D. et al. | 2021 | Science Translational Medicine 13 (577), eabd2223 | 10.1126/scitranslmed.abd2223 |
| Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions among Healthcare Workers of Adult and Pediatric Settings in Central Paris | Contejean A. et al. | 2021 | Clinical Infectious Diseases 72 (2), pp. 257-264 | 10.1093/cid/ciaa977 |
| Origin, evolution and global spread of SARS-CoV-2 | Zhukova A. et al. | 2021 | Comptes Rendus Biologies 344 (1), pp. 57-75 | 10.5802/CRBIOL.29 |
| Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic | Baay M. et al. | 2021 | Biologicals 69, pp. 76-82 | 10.1016/j.biologicals.2020.11.003 |
| SARS-CoV-2 infection in schools in a northern French city: A retrospective serological cohort study in an area of high transmission, France, January to April 2020 | Fontanet A. et al. | 2021 | Eurosurveillance 26 (15), pp. 1-12 | 10.2807/1560-7917.ES.2021.26.15.2001695 |
| SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota | Sokol H. et al. | 2021 | Gut Microbes 13 (1), pp. 1-19 | 10.1080/19490976.2021.1893113 |
| Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification | Garneret P. et al. | 2021 | Plos One 16 (1 January), e0243712 | 10.1371/journal.pone.0243712 |
| High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris | Anna F. et al. | 2021 | European Journal of Immunology 51 (1), pp. 180-190 | 10.1002/eji.202049058 |
| Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020 | Souty C. et al. | 2021 | Infectious Diseases 53 (5), pp. 376-381 | 10.1080/23744235.2021.1880024 |
| Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2 | Scoca V. ; Di Nunzio F. | 2021 | Journal of Molecular Cell Biology 13 (4), pp. 259-268 | 10.1093/jmcb/mjab020 |
| Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93 | Vieira M. et al. | 2021 | Joint Bone Spine 88 (1), 105074 | 10.1016/j.jbspin.2020.09.006 |
| Structure-function relations of the sars-cov-2 spike protein and impact of mutations in the variants of concern | Rey F. | 2021 | Comptes Rendus Biologies 344 (1), pp. 77-110 | 10.5802/CRBIOL.53 |
| IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 | Lévy R. et al. | 2021 | Journal of Clinical Immunology 41 (1), pp. 26-27 | 10.1007/s10875-020-00933-0 |
| A Conceptual Discussion about the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings | Temime L. et al. | 2021 | Clinical Infectious Diseases 72 (1), pp. 141-143 | 10.1093/cid/ciaa682 |
| Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic | Allali S. ; Cohen J.F. ; Brice J. ; Khraiche D. ; Toubiana J. | 2021 | Clinical Chemistry 67 (1), pp. 54-58 | 10.1093/clinchem/hvaa279 |
| Early phylodynamics analysis of the COVID-19 epidemic in France | Danesh G. et al. | 2021 | Peer Community Journal 1, e45 | 10.24072/pcjournal.40 |
| Improving care of migrants is key for viral hepatitis elimination in europe | Kim J.U. ; Ingiliz P. ; Shimakawa Y. ; Lemoine M. | 2021 | Bulletin of the World Health Organization 99 (4), pp. 280-286 | 10.2471/BLT.20.260919 |
| Urban-Rural Disparities for COVID-19: Evidence from 10 Countries and Areas in the Western Pacific | Park M. ; Lim J.T. ; Wang L. ; Cook A.R. ; Dickens B.L. | 2021 | Health Data Science 2021, 9790275 | 10.34133/2021/9790275 |
| Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 (Journal of Clinical Immunology, (2021), 41, 1, (26-27), 10.1007/s10875-020-00933-0) | Lévy R. et al. | 2021 | Journal of Clinical Immunology 41 (1), pp. 28 | 10.1007/s10875-021-00969-w |
| Use of lentiviral vectors in vaccination | Ku M.W. ; Charneau P. ; Majlessi L. | 2021 | Expert Review of Vaccines 20 (12), pp. 1571-1586 | 10.1080/14760584.2021.1988854 |
| Addressing vulnerabilities in communities facing infectious disease threats: A need for social science-driven assessments | Osborne J. et al. | 2021 | Journal of Global Health 11, pp. 1-4 | 10.7189/jogh.11.03003 |
| An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike | Schoof M. et al. | 2020 | Science 370 (6523), pp. 1473-1479 | 10.1126/science.abe3255 |
| Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection | Xu X.K. et al. | 2020 | Clinical Infectious Diseases 71 (12), pp. 3163-3167 | 10.1093/cid/ciaa790 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | Gordon D.E. et al. | 2020 | Science 370 (6521), eabe9403 | 10.1126/science.abe9403 |
| Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: A retrospective matched case–control study, Paris, France, April to May 2020 | Toubiana J. et al. | 2020 | Eurosurveillance 25 (48) | 10.2807/1560-7917.ES.2020.25.48.2001813 |
| Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus | Temmam S. et al. | 2020 | One Health 10, 100164 | 10.1016/j.onehlt.2020.100164 |
| Syncytia formation by SARS-CoV-2-infected cells | Buchrieser J. et al. | 2020 | EMBO Journal 39 (23), e106267 | 10.15252/embj.2020106267 |
| Impact of mass testing during an epidemic rebound of SARS-CoV-2: A modelling study using the example of France | Bosetti P. et al. | 2020 | Eurosurveillance 26 (1) | 10.2807/1560-7917.ES.2020.26.1.2001978 |
| Optimizing COVID-19 surveillance in long-term care facilities: a modelling study | Smith D.R.M. et al. | 2020 | BMC Medicine 18 (1), 386 | 10.1186/s12916-020-01866-6 |
| Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus | Cocozza F. et al. | 2020 | Journal of Extracellular Vesicles 10 (2), e12050 | 10.1002/jev2.12050 |
| COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms | Ostaszewski M. et al. | 2020 | Scientific Data 7 (1), 136 | 10.1038/s41597-020-0477-8 |
| Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel? | Montravers P. ; Kantor E. ; Gouel-Cheron A. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (6), pp. 695-697 | 10.1016/j.accpm.2020.10.004 |
| The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis | Coutard B. et al. | 2020 | Biopreservation and Biobanking 18 (6), pp. 561-569 | 10.1089/bio.2020.0119 |
| A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Huang A.T. et al. | 2020 | Nature Communications 11 (1), 4704 | 10.1038/s41467-020-18450-4 |
| Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms (Scientific Data, (2020), 7, 1, (136), 10.1038/s41597-020-0477-8) | Ostaszewski M. et al. | 2020 | Scientific Data 7 (1), 247 | 10.1038/s41597-020-00589-w |
| Survival of the Wealthiest? | Garfinkel M. ; Sansonetti P.J. ; Pulverer B. | 2020 | EMBO Journal 39 (23), e107227 | 10.15252/embj.2020107227 |
| Complement C5 inhibition in patients with COVID-19 - A promising target? | de Latour R.P. et al. | 2020 | Haematologica 105 (12), pp. 2847-2850 | 10.3324/haematol.2020.260117 |
| SARS-CoV-2 natural transmission from human to Cat, Belgium, March 2020 | Garigliany M. et al. | 2020 | Emerging Infectious Diseases 26 (12), pp. 3069-3071 | 10.3201/EID2612.202223 |
| Epidemiological data from the COVID-19 outbreak, real-time case information | Xu B. et al. | 2020 | Scientific Data 7 (1), 106 | 10.1038/s41597-020-0448-0 |
| A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX) | Mazhari R. et al. | 2020 | Plos One 15 (12 December), e0238010 | 10.1371/journal.pone.0238010 |
| What causes hidradenitis suppurativa ?—15 years after | Zouboulis C.C. et al. | 2020 | Experimental Dermatology 29 (12), pp. 1154-1170 | 10.1111/exd.14214 |
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms | Tortorici M.A. et al. | 2020 | Science 370 (6519), pp. 950-957 | 10.1126/science.abe3354 |
| Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology | Piccoli L. et al. | 2020 | Cell 183 (4), pp. 1024-1042.e21 | 10.1016/j.cell.2020.09.037 |
| First detection and genome sequencing of SARS-CoV-2 in an infected cat in France | Sailleau C. et al. | 2020 | Transboundary and Emerging Diseases 67 (6), pp. 2324-2328 | 10.1111/tbed.13659 |
| A review of the main histopathological findings in coronavirus disease 2019 | Vasquez-Bonilla W.O. et al. | 2020 | Human Pathology 105, pp. 74-83 | 10.1016/j.humpath.2020.07.023 |
| Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong | Adam D.C. et al. | 2020 | Nature Medicine 26 (11), pp. 1714-1719 | 10.1038/s41591-020-1092-0 |
| Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probe | Haddar C. ; Verhoeven P.O. ; Bourlet T. ; Pozzetto B. ; Pillet S. | 2020 | Journal of Clinical Virology 132, 104636 | 10.1016/j.jcv.2020.104636 |
| Animal and translational models of SARS-CoV-2 infection and COVID-19 | Johansen M.D. et al. | 2020 | Mucosal Immunology 13 (6), pp. 877-891 | 10.1038/s41385-020-00340-z |
| COVID-19 and vaccination: A global disruption | Billon-Denis E. ; Tournier J.N. | 2020 | Medecine Sciences 36 (11), pp. 1034-1037 | 10.1051/medsci/2020203 |
| Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study | Annane D. et al. | 2020 | Eclinicalmedicine 28, 100590 | 10.1016/j.eclinm.2020.100590 |
| Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients | Smadja D.M. et al. | 2020 | Angiogenesis 23 (4), pp. 611-620 | 10.1007/s10456-020-09730-0 |
| Implementation of a self-triage web application for suspected COVID-19 and its impact on emergency call centers: Observational study | Galmiche S. et al. | 2020 | Journal of Medical Internet Research 22 (11), e22924 | 10.2196/22924 |
| Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa | Lemoine M. et al. | 2020 | Lancet Gastroenterology and Hepatology 5 (11), pp. 966-967 | 10.1016/S2468-1253(20)30305-8 |
| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 | Bastard P. et al. | 2020 | Science 370 (6515), eabd4585 | 10.1126/science.abd4585 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 | Zhang Q. et al. | 2020 | Science 370 (6515), eabd4570 | 10.1126/science.abd4570 |
| Lockdown impact on COVID-19 epidemics in regions across metropolitan France | Cauchemez S. ; Kiem C.T. ; Paireau J. ; Rolland P. ; Fontanet A. | 2020 | Lancet 396 (10257), pp. 1068-1069 | 10.1016/S0140-6736(20)32034-1 |
| Monitoring approaches for health-care workers during the COVID-19 pandemic | Bielicki J.A. et al. | 2020 | Lancet Infectious Diseases 20 (10), pp. e261-e267 | 10.1016/S1473-3099(20)30458-8 |
| No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation | Cappy P. et al. | 2020 | Blood 136 (16), pp. 1888-1891 | 10.1182/BLOOD.2020008230 |
| COVID-19 herd immunity: where are we? | Fontanet A. ; Cauchemez S. | 2020 | Nature Reviews Immunology 20 (10), pp. 583-584 | 10.1038/s41577-020-00451-5 |
| Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100TM System | Hourdel V. et al. | 2020 | Frontiers in Microbiology 11, 571328 | 10.3389/fmicb.2020.571328 |
| Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates | Maisonnasse P. et al. | 2020 | Nature 585 (7826), pp. 584-587 | 10.1038/s41586-020-2558-4 |
| Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 | Silvin A. et al. | 2020 | Cell 182 (6), pp. 1401-1418.e18 | 10.1016/j.cell.2020.08.002 |
| Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis | Ouldali N. et al. | 2020 | Lancet Child and Adolescent Health 4 (9), pp. 662-668 | 10.1016/S2352-4642(20)30175-9 |
| Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France | Fafi-Kremer S. et al. | 2020 | Ebiomedicine 59, 102915 | 10.1016/j.ebiom.2020.102915 |
| A comprehensive, flexible collection of SARS-CoV-2 coding regions | Kim D.K. et al. | 2020 | G3 Genes Genomes Genetics 10 (9), pp. 3399-3402 | 10.1534/g3.120.401554 |
| COVID-19 in Patients on Maintenance Dialysis in the Paris Region | Tortonese S. et al. | 2020 | Kidney International Reports 5 (9), pp. 1535-1544 | 10.1016/j.ekir.2020.07.016 |
| Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper | Maillard J.Y. et al. | 2020 | American Journal of Infection Control 48 (9), pp. 1090-1099 | 10.1016/j.ajic.2020.04.011 |
| Modeling the inactivation of viruses from the Coronaviridae family in response to temperature and relative humidity in suspensions or on surfaces | Guillier L. et al. | 2020 | Applied and Environmental Microbiology 86 (18), e01244 | 10.1128/AEM.01244-20 |
| Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions | Ali S.T. et al. | 2020 | Science 369 (6507), pp. 1106-1109 | 10.1126/science.abc9004 |
| Characterization of accessory genes in coronavirus genomes | Michel C.J. ; Mayer C. ; Poch O. ; Thompson J.D. | 2020 | Virology Journal 17 (1), 131 | 10.1186/s12985-020-01402-1 |
| Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients | Hadjadj J. et al. | 2020 | Science 369 (6504), pp. 718-724 | 10.1126/science.abc6027 |
| The Global Phosphorylation Landscape of SARS-CoV-2 Infection | Bouhaddou M. et al. | 2020 | Cell 182 (3), pp. 685-712.e19 | 10.1016/j.cell.2020.06.034 |
| Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort | Pouletty M. et al. | 2020 | Annals of the Rheumatic Diseases 79 (8), pp. 999-1006 | 10.1136/annrheumdis-2020-217960 |
| Delayed laboratory response to COVID-19 caused by molecular diagnostic contamination | Mögling R. et al. | 2020 | Emerging Infectious Diseases 26 (8), pp. 1944-1946 | 10.3201/eid2608.201843 |
| A race against the clock: Creation of SARS-CoV-2 in the laboratory, a month after its emergence! | Iseni F. ; Tournier J.N. | 2020 | Medecine Sciences 36 (8-9), pp. 797-801 | 10.1051/medsci/2020124 |
| Structural insight into the role of novel SARSCoV-2 E protein: A potential target for vaccine development and other therapeutic strategies | Sarkar M. ; Saha S. | 2020 | Plos One 15 (8 August), e0237300 | 10.1371/journal.pone.0237300 |
| Minimising COVID-19 exposure during tracheal intubation by using a transparent plastic box: A randomised prospective simulation study | Clariot S. ; Dumain G. ; Gauci E. ; Langeron O. ; Levesque É. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (4), pp. 461-463 | 10.1016/j.accpm.2020.06.005 |
| An Old Cytokine against a New Virus | Pellegrini S. ; Uzé G. | 2020 | Journal of Interferon and Cytokine Research 40 (8), pp. 425-428 | 10.1089/jir.2020.0130 |
| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion | Verweij P.E. et al. | 2020 | Intensive Care Medicine 46 (8), pp. 1524-1535 | 10.1007/s00134-020-06091-6 |
| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | Gordon D.E. et al. | 2020 | Nature 583 (7816), pp. 459-468 | 10.1038/s41586-020-2286-9 |
| Estimating the burden of SARS-CoV-2 in France | Salje H. et al. | 2020 | Science 369 (6500), pp. 208-211 | 10.1126/science.abc3517 |
| Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody | Pinto D. et al. | 2020 | Nature 583 (7815), pp. 290-295 | 10.1038/s41586-020-2349-y |
| SARS-CoV-2: Virology, epidemiology, immunology and vaccine development | Baay M. et al. | 2020 | Biologicals 66, pp. 35-40 | 10.1016/j.biologicals.2020.06.005 |
| Interplay between SARS-CoV-2 and the type I interferon response | Ribero M.S. ; Jouvenet N. ; Dreux M. ; Nisole S. | 2020 | Plos Pathogens 16 (7), e1008737 | 10.1371/journal.ppat.1008737 |
| A hybrid approach to tracheostomy in COVID-19 patients ensuring staff safety | Tanaka L. et al. | 2020 | British Journal of Surgery 107 (8), pp. e253-e254 | 10.1002/bjs.11705 |
| Working from home in the time of COVID-19: How to best preserve occupational health? | Bouziri H. et al. | 2020 | Occupational and Environmental Medicine 77 (7), pp. 509-510 | 10.1136/oemed-2020-106599 |
| Planetary health: young academics ask universities to act | Wabnitz K.J. et al. | 2020 | Lancet Planetary Health 4 (7), pp. e257-e258 | 10.1016/S2542-5196(20)30142-X |
| Knowledge, attitude, and perceptions towards the 2019 Coronavirus Pandemic: A bi-national survey in Africa | Hager E. et al. | 2020 | Plos One 15 (7 July), e0236918 | 10.1371/journal.pone.0236918 |
| Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients | Bost P. et al. | 2020 | Cell 181 (7), pp. 1475-1488.e12 | 10.1016/j.cell.2020.05.006 |
| Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable | Mavian C. et al. | 2020 | Proceedings of the National Academy of Sciences of the United States of America 117 (23), pp. 12522-12523 | 10.1073/pnas.2007295117 |
| Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study | Toubiana J. et al. | 2020 | BMJ Clinical Research Ed 369, pp. m2094 | 10.1136/bmj.m2094 |
| Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases | von Lilienfeld-Toal M. et al. | 2020 | Leukemia 34 (6), pp. 1487-1494 | 10.1038/s41375-020-0832-y |
| Clinical and virological data of the first cases of COVID-19 in Europe: a case series | Lescure F.X. et al. | 2020 | Lancet Infectious Diseases 20 (6), pp. 697-706 | 10.1016/S1473-3099(20)30200-0 |
| Repurposing chlorpromazine to treat COVID-19: The reCoVery study | Plaze M. et al. | 2020 | Encephale 46 (3), pp. 169-172 | 10.1016/j.encep.2020.05.006 |
| Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study | Plaze M. et al. | 2020 | Encephale 46 (3), pp. S35-S39 | 10.1016/j.encep.2020.04.010 |
| French psychiatry and the novelty of the COVID-19 crisis | Masson M. ; Gaillard R. | 2020 | Encephale 46 (3), pp. S1-S2 | 10.1016/j.encep.2020.06.001 |
| Epidemiological Observations on the Association between Anosmia and COVID-19 Infection: Analysis of Data from a Self-Assessment Web Application | Denis F. et al. | 2020 | Journal of Medical Internet Research 22 (6), e19855 | 10.2196/19855 |
| Serial interval of COVID-19 among publicly reported confirmed cases | Du Z. et al. | 2020 | Emerging Infectious Diseases 26 (6), pp. 1341-1343 | 10.3201/EID2606.200357 |
| Invasive fungal diseases during COVID-19: We should be prepared | Gangneux J.P. ; Bougnoux M.E. ; Dannaoui E. ; Cornet M. ; Zahar J.R. | 2020 | Journal De Mycologie Medicale 30 (2), 100971 | 10.1016/j.mycmed.2020.100971 |
| Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 | Alanio A. ; Dellière S. ; Fodil S. ; Bretagne S. ; Mégarbane B. | 2020 | Lancet Respiratory Medicine 8 (6), pp. e48-e49 | 10.1016/S2213-2600(20)30237-X |
| Preliminary observations of anaesthesia ventilators use for prolonged mechanical ventilation in intensive care unit patients during the COVID-19 pandemic | Gouel-Cheron A. ; Couffignal C. ; Elmaleh Y. ; Kantor E. ; Montravers P. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (3), pp. 371-372 | 10.1016/j.accpm.2020.04.009 |
| Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients | Bonam S.R. ; Kaveri S.V. ; Sakuntabhai A. ; Gilardin L. ; Bayry J. | 2020 | Cell Reports Medicine 1 (2), 100016 | 10.1016/j.xcrm.2020.100016 |
| COVID-19, chronicle of an expected pandemic | Sansonetti P.J. | 2020 | EMBO Molecular Medicine 12 (5), e12463 | 10.15252/emmm.202012463 |
| Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays | Crawford K.H.D. et al. | 2020 | Viruses 12 (5), 513 | 10.3390/v12050513 |
| The effect of human mobility and control measures on the COVID-19 epidemic in China | Kraemer M.U.G. et al. | 2020 | Science 368 (6490), pp. 493-497 | 10.1126/science.abb4218 |
| Risk for transportation of coronavirus disease from Wuhan to other cities in China | Du Z. et al. | 2020 | Emerging Infectious Diseases 26 (5), pp. 1049-1052 | 10.3201/eid2605.200146 |
| Chloroquine and COVID-19, where do we stand? | Lecuit M. | 2020 | Medecine Et Maladies Infectieuses 50 (3), pp. 229-230 | 10.1016/j.medmal.2020.03.004 |
| Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | Walls A.C. et al. | 2020 | Cell 181 (2), pp. 281-292.e6 | 10.1016/j.cell.2020.02.058 |
| Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 | Boëlle P.Y. et al. | 2020 | Eurosurveillance 25 (14), 2000326 | 10.2807/1560-7917.ES.2020.25.14.2000326 |
| Facing challenges with the novel coronavirus SARS-CoV-2 outbreak | van der Werf S. ; Peltekian C. | 2020 | Virologie Montrouge France 24 (S1), pp. e12-e15 | 10.1684/vir.2020.0826 |
| Coronavirus outbreak: the role of companies in preparedness and responses | Fadel M. ; Salomon J. ; Descatha A. | 2020 | Lancet Public Health 5 (4), pp. e193 | 10.1016/S2468-2667(20)30051-7 |
| First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 | Spiteri G. et al. | 2020 | Eurosurveillance 25 (9), 2000178 | 10.2807/1560-7917.ES.2020.25.9.2000178 |
| First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures, January 2020 | Stoecklin S.B. et al. | 2020 | Eurosurveillance 25 (6), 2000094 | 10.2807/1560-7917.ES.2020.25.6.2000094 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations | Grzelak L. et al. | 2020 | Science Translational Medicine 12 (559), eabc3103 | 10.1126/SCITRANSLMED.ABC3103 |
| Rapid detection of COVID-19 by serological methods and the evaluation of diagnostic efficacy of IgM and IgG | Huang S. et al. | 2020 | Clinical Laboratory 66 (11), pp. 2327-2333 | 10.7754/Clin.Lab.2020.200617 |
| A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications | Changeux J.P. ; Amoura Z. ; Rey F.A. ; Miyara M. | 2020 | Comptes Rendus Biologies 343 (1), pp. 33-39 | 10.5802/crbiol.8 |
| Introductions and early spread of SARS-CoV-2 in france, 24 january to 23 march 2020 | Gámbaro F. et al. | 2020 | Eurosurveillance 25 (26) | 10.2807/1560-7917.ES.2020.25.26.2001200 |
| Highly performing point-of-care molecular testing for sars-cov-2 with RNA extraction and isothermal amplificaiton | Coz E. et al. | 2020 | Microtas 2020 24th International Conference on Miniaturized Systems for Chemistry and Life Sciences , pp. 1232-1233 | |
| COVID-19 and socioeconomic development in Africa: The first 6 months (february 2020-august 2020) | Garenne M.M. | 2020 | International Journal of Population Studies 6 (2), pp. 1-14 | 10.18063/ijps.v6i2.1222 |
| Randomized controlled study evaluating efficiency of low intensity transcranial direct current stimulation (TDCS) for dyspnea relief in mechanically ventilated COVID-19 patients in ICU: The tDCS-DYSP-COVID protocol | Azabou E. et al. | 2020 | Frontiers in Medicine 7, 372 | 10.3389/fmed.2020.00372 |
| Development of vaccines at the time of COVID-19 | Almond J. et al. | 2020 | Microlife 1 (1), uqaa003 | 10.1093/femsml/uqaa003 |
| Pandemic legion history more complex than previously thought | Tournier J.N. | 2020 | Mbio 11 (5), e02377-20 | 10.1128/mBio.02377-20 |
Préparer votre voyage
Le centre médical de l'Institut Pasteur accompagne les voyageurs dans la préparation médicale de leur périple. Zones à risque, vaccinations, fiches maladies, retrouvez ici l'ensemble de nos recommandations sanitaires pour bien préparer votre voyage.
Press documents
02.09.2025
Des scientifiques de l’Institut Pasteur ont réalisé des analyses génétiques sur des restes d’anciens soldats de la...
29.07.2025
Plusieurs mois après l’infection au SARS-CoV-2, des symptômes peuvent perdurer chez certains patients. Les...
25.07.2025
Et si les bactéries détenaient les clés d’une partie de notre propre immunité ? Depuis quelques années, certains...